|
| |
 |
| REVIEW ARTICLE |
|
| Year : 2016 | Volume
: 20
| Issue : 4 | Page : 546-551 |
|
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
Aastha Chawla1, Rajeev Chawla1, Shalini Jaggi2
1 North Delhi Diabetes Centre, New Delhi, India
2 Sri Balaji Action Medical Institute, New Delhi, India
| Date of Web Publication | 3-Jun-2016 |
Correspondence Address:
Rajeev Chawla
North Delhi Diabetes Centre, Rohini, New Delhi - 110 085
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.183480
 Abstract | | |
Diabetes and related complications are associated with long-term damage and failure of various organ systems. The line of demarcation between the pathogenic mechanisms of microvascular and macrovascular complications of diabetes and differing responses to therapeutic interventions is blurred. Diabetes induces changes in the microvasculature, causing extracellular matrix protein synthesis, and capillary basement membrane thickening which are the pathognomic features of diabetic microangiopathy. These changes in conjunction with advanced glycation end products, oxidative stress, low grade inflammation, and neovascularization of vasa vasorum can lead to macrovascular complications. Hyperglycemia is the principal cause of microvasculopathy but also appears to play an important role in causation of macrovasculopathy. There is thought to be an intersection between micro and macro vascular complications, but the two disorders seem to be strongly interconnected, with micro vascular diseases promoting atherosclerosis through processes such as hypoxia and changes in vasa vasorum. It is thus imperative to understand whether microvascular complications distinctly precede macrovascular complications or do both of them progress simultaneously as a continuum. This will allow re-focusing on the clinical issues with a unifying perspective which can improve type 2 diabetes mellitus outcomes.
Keywords: Complications, diabetes, macrovascular, microvascular
How to cite this article:
Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J Endocr Metab 2016;20:546-51 |
How to cite this URL:
Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J Endocr Metab [serial online] 2016 [cited 2021 Jan 15];20:546-51. Available from: https://www.ijem.in/text.asp?2016/20/4/546/183480 |
| Introduction | |  |
Diabetes mellitus (DM) has routinely been described as a metabolic disorder characterized by hyperglycemia that develops as a consequence of defects in insulin secretion, insulin action, or both. Type 2 diabetes encompasses individuals who have insulin resistance (IR) and usually relative (rather than absolute) insulin deficiency.[1] The pathologic hallmark of DM involves the vasculature leading to both microvascular and macrovascular complications.[2] Chronicity of hyperglycemia is associated with long-term damage and failure of various organ systems mainly affecting the eyes, nerves, kidneys, and the heart.[1]
According to diabetes atlas (7th edition), the global prevalence of diabetes is estimated at 415 million (8.8%), which is predicted to rise to 642 million in next 25 years.[3] In India, there are about 69.2 million people with diabetes and are expected to cross 123.5 million by 2040.[3] Moreover, worldwide approximately 193 million diabetics remain undiagnosed predisposing them to the development of several long-term complications of untreated chronic hyperglycemia.[3] Although intensive glycemic control lowers the incidence and progression of microvascular complications, the morbidity associated with these complications is still increasing.[4] Several landmark studies such as the United Kingdom Prospective Diabetes Study (UKPDS) have demonstrated that strict glycemic control does limit microvascular disease while attempts to improve macrovascular outcomes through glucose-lowering interventions still remain shrouded with controversy. A relative risk (RR) reduction in myocardial infarction (MI) (P = 0.052) has been observed in the 10 years of posttrial follow-up of UKPDS.[5] Similarly, the risk of cardiovascular mortality, nonfatal MI and stroke reduced with pioglitazone in the Prospective Pioglitazone Clinical Trial in Macrovascular Events as compared to placebo group.[6] The action in diabetes and vascular disease: Preterax and Diamicron MR Controlled Evaluation and the Veterans Affairs Diabetes Trial failed to show any significant improvement in cardiovascular risk with the intensification of diabetes therapy.[7],[8] To further complicate matters, in Action to Control Cardiovascular Risk in Diabetes trial the use of intensive therapy for 3.5 years increased mortality but did not significantly reduce major cardiovascular events.[9]
In recent years, much attention has been focused on the management of macrovascular complications such as stroke and acute coronary syndromes. It is well-recognized that vascular complications in a given tissue are often accompanied by evidence of pathology in other vascular territories. A linear relationship between microvascular complications and duration of disease was established by the authors where they documented the presence of microvasculopathy across different age groups in their study in 25–40% of diabetic patients aged >25 years with more than 5 years duration of diabetes.[10] Researchers such as Krentz et al. and Al-Wakeel et al. have observed that both microvascular and macrovascular complications develop simultaneously in diabetes.[11],[12] On the contrary, Matheus and Gomes described the case report of type 1 DM (T1DM) patient with early and aggressive coronary artery disease (CAD) without evidence of nephropathy, retinopathy, or classical risk factors for CAD.[13] Thus, there is not much clarity over whether microvascular complication precedes macrovascular complications or they progress simultaneously.
The present review attempts an insight into this delicate relationship between microvascular and macrovascular complications of diabetes to understand whether they are discrete entities or in continuum with each other. We propose a unique continuum bridging the microvascular and the macrovascular risk which is based on our evidence-based studies consistently over a decade.
| Pathophysiological Basis of Micro Versus Macrovascular Complications | | |
Patients with DM and associated microvascular complications appear particularly at higher risk of accelerated atherosclerosis which ultimately culminates in cerebrovascular and cardiovascular events and premature death.[14] Microvessels are the basic functional unit of the cardiovascular system comprising of arterioles, capillaries, and venules.[2] They differ from macrovessels in both their architecture and cellular components. In contrast to macrovessels supplying blood to organs, microvessels play important roles in maintaining blood pressure and proper nutrient delivery.[2] The microcirculation also has regulatory systems controlling vascular permeability and myogenic responses that can adapt blood flow according to local metabolic needs. Alteration in microvascular function may arise even before overt hyperglycemia and vascular pathologic changes manifest. Diabetes induces pathognomonic changes in the microvasculature, affecting the capillary basement membrane including arterioles in the glomeruli, retina, myocardium, skin, and muscle, by increasing their thickness, leading to the development of diabetic microangiopathy. This thickening eventually leads to abnormality in vessel function, inducing multiple clinical problems such as hypertension, delayed wound healing, and tissue hypoxia. Similarly, neovascularization arising from the vasa vasorum may interconnect macro-and microangiopathy, predict platelet rupture and promote atherosclerosis. The role of microvascular pathology in systemic diabetic complications, including macrovascular atherosclerosis, remains a subject for further debate.[2]
| Intersection of Microvascular and Macrovascular Complications of Diabetes: Evidence-Based Proof of Concept | | |
Diabetic retinopathy
The risk of development of diabetic retinopathy (DR) in patients with (T2DM) has been found to be related to both severities of hyperglycemia and presence of hypertension. Fong et al. attributed approximately 10,000 new cases of blindness to DR in the United States.[15] In India, The Chennai Urban Rural Epidemiology Study (CURES) reported an overall DR prevalence of 17.6% (confidence interval [95% CI]: 15.8–19.5) in the diabetic population.[16] More recently, the Sankara Nethralaya DR Epidemiology and Molecular Genetic Study has estimated an urban prevalence of 18.0% (95% CI: 16.0–20.1) and a rural prevalence of 10.3% (95% CI: 8.53–11.97%) of DR in South India.[17],[18] Similar to this, Aravind Comprehensive Eye Study has reported 10.5% prevalence of DR (in self-reported subjects with diabetes) in the rural South Indian population.[19] A DR prevalence of 21.2% has been reported by Chawla et al. in their cohort of North Indian patients. This study also found a significant association between HbA1c, body mass index, duration of diabetes and microalbuminuria in the development of DR (P = 0.001).[20]
Several studies have explored the association between DR and macrovascular complications. As retinal microvasculature shares embryologic and anatomic characteristics with that of cerebral circulation, researchers have studied retinal abnormalities to provide clues to understand the underlying pathophysiology of different cerebrovascular diseases.[21] In the World Health Organization Multinational Study of Vascular Disease in Diabetes, retinopathy was related to the incidence of MI and death from cardiovascular disease (CVD).[22] In the Atherosclerosis Risk in Communities study, increased incidence of clinical stroke was associated with retinal microvascular abnormalities and generalized arteriolar narrowing.[23] Furthermore, retinopathy was significantly associated with combined stroke events (RR 1.7, 95% CI: 1.0–2.8) in persons without diabetes after controlling for age, sex, and systolic blood pressure. This association was stronger in those with two or more retinal microvascular signs (RR 2.7, CI: 1.5–5.2).[24] Targher et al. followed up 2103 T2DM outpatients for 7 years and found a remarkably increased risk of incident CVD in patients with proliferative/laser-treated retinopathy (hazard ratio 2.08 [1.02–3.7] for men and 2.41 [1.05–3.9] for women), after adjustment of hypertension and advanced nephropathy.[25] Contrary to this, Matheus and Gomes has reported cardiovascular events without any presence of retinopathy.[13]
Diabetic nephropathy
Proteinuria occurs in 15–40% of patients with type 1 diabetes while it ranges from 5 to 20% in patients with T2DM.[26] According to the European Diabetes Prospective Complications Study, the cumulative incidence of microalbuminuria was 12.6% over 7.3 years in patients with T1DM.[26] However, 18 years follow-up study from Denmark reported a prevalence rate of 33% in the T1DM population.[27] Similarly, in the (UKPDS), T2DM patients showed a 2.0% incidence of microalbuminuria per year, which reached up to 25% in 10 years postdiagnosis.[28] The prevalence of diabetic nephropathy was higher in African Americans, Asians, and Native Americans than Caucasians.[26] In India, CURES 45 reported a prevalence of 2.2% for overt diabetic nephropathy and 26.9% for microalbuminuria.[29]
The association of intense control to reduced microvascular complication, as reported by the Diabetes Control and Complications Trial, has emerged as a strong proof of concept for hyperglycemia being an important modifiable risk factor for diabetic nephropathy. A reduction in 10 mm Hg of systolic blood pressure is associated with a 13% decrease in the microvascular complications with minimal risk in patient with a systolic pressure <120 mm Hg.[30] Dyslipidemia with increased low-density lipoprotein (LDL) cholesterol and triglycerides is independently associated with diabetic kidney disease.[31]
The pathogenic mechanisms underlying diabetic nephropathy involve generation of reactive oxygen species (ROS), accumulation of advanced glycation end product (AGE), and activation of intracellular signaling molecules such as protein kinase C (PKC).[32],[33] A strong association between diabetic nephropathy and retinopathy was demonstrated by Arora et al. in 2004–2005 in 50 newly diagnosed patients with diabetes.[34] The direct association between the presence of microalbuminuria and macrovascular complications has also been well-established in many studies.[35] In an observational study, Hägg et al(2013). reported the increased incidence of both cerebral infarction and cerebral hemorrhage in patients with severe DR (SDR) and advanced diabetic nephropathy in 4083 patients with T1DM with 36,680 person-years of follow-up. Both nephropathy and SDR were found to be independently increasing the risk for all subtypes of stroke.[36] The increased incidence of stroke in diabetic nephropathy has also been reiterated in the Pittsburgh Epidemiology of Diabetes Complications study, where overt nephropathy increases the risk of ischemic stroke 4.4-fold (but not the risk for hemorrhagic stroke, probably due to the insufficient number of samples).[36] Retinopathy and macroalbuminuria produce higher rates of cardiovascular events among Chinese patients.[37]
Diabetic neuropathy
Diabetic neuropathy, a life-threatening complication involves both peripheral and autonomic nerves, affecting almost half of the diabetic population.[38] The risk of development of diabetic neuropathy is directly proportional to both the duration and magnitude of hyperglycemia. In addition, some individuals may also possess genetic facets that influence their predisposition in developing such complications.[35] The prevalence of diabetic neuropathy varies from country to country. In India, a high prevalence (29.2%) of diabetic peripheral neuropathy was reported among the North Indian population.[39] Further studies in North Indian region (Lucknow) and North-eastern region (Imphal) revealed a prevalence of 29.2% and 29.0%, respectively, among newly diagnosed diabetic patients (duration <6 months).[40],[41] Chawla et al. reported the prevalence of 15.3% in their study involving 720 North Indian patients from New Delhi.[20]
Although the precise nature of the injury to the peripheral nerves from hyperglycemia is not yet certain, the mechanisms of hyperglycemia-induced polyol pathway, injury from AGEs, and enhanced oxidative stress have been implicated in its pathogenesis. The damage to peripheral nerves may be mediated by effects on nerve tissue or by endothelial injury or vascular dysfunction.[2] Peripheral neuropathy in diabetes appears in several forms depending on the site, manifesting as sensory, focal/multifocal, and autonomic neuropathies. Diabetic neuropathy has resulted in more than 80% amputations after foot ulceration or injury.[35]
A study conducted by Miguel et al. demonstrated a significant correlation between diabetic neuropathy and the existence of one or more macrovascular complications showing that diabetic patients with peripheral neuropathy presented with significantly higher rates of cardiac events and peripheral vascular disease (PVD) than diabetic patients without neuropathy. Strokes were also numerically higher in the neuropathy group.[42] Chawla et al. in 2011–2012 demonstrated an association between diabetic neuropathy and development of DR and microalbuminuria in 855 patients.[43] Diabetic cardiac autonomic neuropathy have been found to have a strong co-association with DR (22% vs. 14.3%), diabetic neuropathy (14% vs. 6.8%), and poor glycemic control.
Hence, it is recommended to evaluate autonomic nervous system function at the time of T2DM diagnosis and annually thereafter.[44] Chawla et al. established a positive correlation between autonomic neuropathy and peripheral neuropathy (P = 0.00014); however, the further association between autonomic neuropathy and PVD failed to reach statistical significance.[45] In addition, a direct relationship of lower extremity arterial disease (LEAD) with T2DM was also documented by Chawla et al. They found symptoms of peripheral vascular insufficiency or weak peripheral vessels in 13.8% of patients with foot Doppler confirmed the prevalence of LEAD in 7.4% of patients.[46] The authors validated and advocate the use of neuropathy symptoms score and neuropathy disability score in the clinical and bedside diagnosis of peripheral neuropathy.[47]
| Common Pathways for Development of Both Micro and Macrovascular Complications | | |
Advanced glycation products
AGEs are a heterogeneous group of molecules formed by the nonenzymatic glycation of plasma proteins causing a disruption in their normal functioning by altering their molecular conformation, disrupting enzyme activity, and interfering with receptor functioning. AGEs accumulate in different types of cells and affect their extracellular and intracellular structure and function by cross-linking not only with proteins but also lipids and nucleic acids contributing to a variety of diabetic complications.[48] AGEs crosslink with plasma membrane-localized receptors for AGEs (RAGE) leading to up-regulation of transcription factors such as nuclear factor-κB and its target genes, release of pro-inflammatory molecules and free radicals. Soluble AGEs activate monocytes, and AGEs in the basement membrane inhibit monocyte migration. AGE-bound RAGE increases endothelial permeability to macromolecules. AGEs block nitric oxide activity in the endothelium and cause the production of ROS.[49]
Further, AGEs modify LDL particles and together with vascular damage accelerate atherosclerosis.[50] Kalousová et al. found significant elevation of AGE in patients with T2DM as compared to both healthy (5.11 ± 1.15 × 103 AU/g vs. 4.08 ± 0.71 × 103 AU/g, P < 0.001) as well as T1DM patients (4.14 ± 0.86 × 103 AU/g, P < 0.005).[51] Kilhovd et al. demonstrated a significant increase in the levels of AGEs in patients with T2DM compared with nondiabetic control subjects (7.4 [4.4–10.9] vs. 4.2 [1.6–6.4] U/ml, P < 0.0001). Besides, they also found elevated levels of AGE in patients with coronary heart disease (CHD) than those of without CHD (8.1 [6.4–10.9] vs. 7.1 [3.5–9.8] U/ml, P = 0.03) in patients with T2DM.[52]
Oxidative stress
Oxidative stress, caused by the overproduction of ROS plays an important role in the activation of other pathogenic pathways involved in diabetic complications, including elevated polyol pathway activity, nonenzymatic glycation, and PKC levels which in turn lead to the development of micro-and macrovascular complications.[53] It also inactivates two critical anti-atherosclerotic enzymes, endothelial nitric oxide synthase, and prostacyclin synthase.[54] Hyperglycemia promotes the formation of ROS, which interacts with both deoxyribonucleic acid (DNA) and proteins, causing cellular damage, especially targeting mitochondrial DNA. A study on the human retinal endothelial cell (EC) demonstrated very early mitochondrial DNA damage with hyperglycemia-induced overproduction of ROS.[55] ROS-mediated cellular damage may be a form of pathologic “memory” in the microvasculature that persists even after glucose normalization. Several experimental evidences point to mitochondrial superoxide overproduction as the major culprit in the development of metabolic abnormalities in diabetics.[56] IR induces mitochondrial ROS production from free fatty acids and inhibits anti-atherosclerotic enzymes causing atherosclerosis and cardiomyopathy in T2DM patients. In subjects without diabetes or impaired glucose tolerance, those in the highest quintile of IR had a 2.0-fold increase in CVD risk compared to those in the lowest quintile after adjusting several known cardiovascular risk factors, including LDL, triglycerides, high-density lipoprotein, systolic blood pressure, and smoking.[57]
The other pathways implicated in diabetic complications such as AGE formation, PKC activation, increased polyol flux, and hexosamine formation are also linked to oxidative stress in promoting macrovascular complications through multiple mechanisms. Increased glucose concentrations can activate nuclear factor-κB, a key mediator that regulates multiple pro-inflammatory and pro-atherosclerotic target genes in vascular smooth muscle cells (VSMCs), ECs, and macrophages.[55] Hyperglycemia itself stimulates oxidative stress, which indeed acts as a driving force in accelerated atherosclerosis.
Low-grade inflammation
Inflammation has been recognized as one of the potent risk factors in both atherosclerosis and T2DM. Vascular cells encounter many early pathologic changes in response to hyperglycemia, causing a loss of nonadhesive property and adhesion of monocyte to ECs, which is an early step in atherogenesis. Hyperglycemia has been reported to provoke monocyte adhesion to arterial ECs.[58] The association between hyperglycemia and AGEs with oxidative stress is manifested as both can stimulate EC production of superoxide [Figure 1]. Glucose also activates matrix-degrading enzyme metalloproteinase which causes plaque rupture and arterial remodeling as well as VSMC proliferation, migration and altered activity. The role of increased level of tumor necrosis factor alpha in the development of IR is well-documented. IR itself has inflammatory action as described above. The levels of several other inflammatory markers such as C-reactive protein, fibrinogen, plasminogen activator inhibitor I, and interleukine-6 have been shown to increase with the onset of diabetes. Monocyte activation has been documented in the presence of high glucose with induction of inflammatory mediators such as PKC and nuclear factor-κB promoting oxidative stress.[59] | Figure 1: Insulin resistance and hyperglycemia drive the atherosclerotic process
Click here to view |
Neovascularization of vasa vasorum
The proliferation of vasa vasorum is associated with increased plaque burden, which subsequently promotes atherosclerosis.[60] Many cellular processes such as inflammation, plaque perfusion and concomitant intra-plaque hemorrhage are critical during the development of atherosclerotic plaques and are linked with vasa vasorum proliferation. Neovascularization develops by the growth from both adventitial layer (outward) and arterial lumen (inward) toward the intima.[61] In T2DM, plaque rupture is associated with increased angiogenesis, and diabetic atherosclerosis is further accelerated by neovasculature microangiopathy.[62] The initial angiogenic response in the adventitial vasa vasorum, an important component of homeostatic mechanisms, appears to be stimulated by hypoxia through identification of increased hypoxia-inducible factor and vascular endothelial growth factor (VEGF) action.[63]
VEGF, a multifunctional cytokine, also contributes to microvascular complications by increasing the vascular permeability to macromolecules, monocyte chemotaxis, and tissue factor production.[64] Up-regulation of VEGF is also reported in experimental diabetic kidney disease models. However, contrary to this, VEGF treatment has been shown to restore microcirculation in the vasa nervorum and limit diabetic neuropathy as demonstrated by rodent VEGF gene transfer experiment.[2] In the eye, a neurotropic factor-pigment epithelium-derived factor (PEDF) may offset VEGF action by its potent angiogenic inhibition.[65] PEDF level is decreased in proliferative DR, whereas VEGF levels are increased. Decreased PEDF levels may also likely contribute to diabetic nephropathy. Other growth factors such as insulin-like growth factor 1, basic fibroblast growth factor, and hepatocyte growth factor may foster proliferative retinopathy.[66]
| Microvascular and Macrovascular Complications-Continuum or Separate: The Debate Continues | | |
[Figure 2]
Heart involvement in diabetes may not be only a macrovascular disease where there is Orchestra of contributing factors to the development of diabetic cardiomyopathy concerning fatty acid and glucose complex structural macrovascular derangements such as hypertrophy and loss of function due to glycation but also a microvascular involvement following “common soil” hypothesis of diabetes complications. Atherosclerosis in large arteries as well as cardiomyopathy in diabetes a microvascular component may go hand in hand.[67]
Therefore, changes in small arteries and capillaries are not responsible for only microvascular long-term complications in patients with diabetes (retinopathy, nephropathy, and neuropathy) but also for other manifestations of heart disease in diabetes.
This review highlights the need for implementing programs for early detection, screening, and awareness to mitigate the burden of managing the complications.
Good blood glucose control improves microvascular disease and should be implemented early and maintained for the optimum length of time. Appropriate controls of blood pressure as well as dyslipidemia are extremely important in macrovascular disease prevention besides glycemic control. Patients with microvascular complications appear particularly prone to accelerated atherosclerosis and premature death. Neovascularization arising from the vasa vasorum may interconnect macro-and microangiopathy.
A clearer picture on differing responses to therapeutic interventions could lead to better management and improve T2DM outcomes not only regarding microvascular but also macrovascular complications as well. Further systematic research on the above interlinking hypothesis will help us get more clarity whether microvascular complications precede macrovascular complications or they are two ends of the same spectrum of disease existing in continuum.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Standards of medical care in diabetes-2016: Summary of revisions. Diabetes Care 2016;39 Suppl 1:S4-5.  |
| 2. | Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009;53 5 Suppl:S35-42. |
| 3. | |
| 4. | ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72. |
| 5. | Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89. |
| 6. | Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A; PROactive Study Group. The prospective pioglitazone clinical trial in macrovascular events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Diabetes Care 2004;27:1647-53. |
| 7. | Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39. |
| 8. | Patel A, Chalmers J, Poulter N. ADVANCE: Action in diabetes and vascular disease. J Hum Hypertens 2005;19 Suppl 1:S27-32. |
| 9. | Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr., Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59. |
| 10. | Chawla A, Chawla R, Bhasin GK, Soota K. Profile of adolescent diabetics in North Indian population. J Clin Diabetol 2014;1:1-3. |
| 11. | Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: Pathophysiology and therapeutic implications. Diabetes Obes Metab 2007;9:781-91. |
| 12. | Al-Wakeel JS, Hammad D, Al Suwaida A, Mitwalli AH, Memon NA, Sulimani F. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic. Saudi J Kidney Dis Transpl 2009;20:77-85. [ PUBMED]  |
| 13. | Matheus AS, Gomes MB. Early aggressive macrovascular disease and type 1 diabetes mellitus without chronic complications: A case report. BMC Res Notes 2013;6:222. |
| 14. | Kalofoutis C, Piperi C, Kalofoutis A, Harris F, Phoenix D, Singh J. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches. Exp Clin Cardiol 2007;12:17-28. |
| 15. | Fong DS, Aiello LP, Ferris FL 3 rd, Klein R. Diabetic retinopathy. Diabetes Care 2004;27:2540-53. |
| 16. | Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328-33. |
| 17. | Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009;116:311-8. |
| 18. | Raman R, Ganesan S, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care 2014;2:e000005. |
| 19. | Nirmalan PK, Tielsch JM, Katz J, Thulasiraj RD, Krishnadas R, Ramakrishnan R, et al. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: The Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 2005;46:2308-12. |
| 20. | Chawla A, Chawla R, Chawla A. Correlation Between Retinopathy Microalbuminuria and Other Modifiable Risk Factors. Presented on American Diabetes Association's 75 th Scientific Session; June 5-9; Boston, Massachusetts; 2015. |
| 21. | Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, et al. Retinal microvascular abnormalities and incident stroke: The atherosclerosis risk in communities study. Lancet 2001;358:1134-40. |
| 22. | Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: The WHO mutinational study of vascular disease in diabetes. Diabetologia 2001;44 Suppl 2:S54-64. |
| 23. | Yatsuya H, Folsom AR, Wong TY, Klein R, Klein BE, Sharrett AR; ARIC Study Investigators. Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis risk in communities study. Stroke 2010;41:1349-55. |
| 24. | Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 2005;65:1005-9. |
| 25. | Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabet Med 2008;25:45-50. |
| 26. | Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-76. |
| 27. | Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: The EURODIAB prospective complications study (PCS). Diabetes Care 2008;31:1360-6. |
| 28. | Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study. BMJ 2004;328:1105. |
| 29. | Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS Group. Development and progression of nephropathy in type 2 diabetes: The United Kingdom prospective diabetes study (UKPDS 64). Kidney Int 2003;63:225-32. |
| 30. | Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: The Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007;30:2019-24. |
| 31. | Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ 2000;321:412-9. |
| 32. | Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease. J Am Soc Nephrol 2006;17 4 Suppl 2:S145-7. |
| 33. | Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008;88:1322-35. |
| 34. | Arora GS, Chawla R, Ahuja CP. To Evaluate the Clinical Profile and Determine the Prevalence of Complications in Newly Detected Type-2 Diabetes Patients. Presented on Research Society for the Study of Diabetes in India's (RSSDI) 33 rd Annual Conference; September 23 rd-25 th, Bangalore; 2005. |
| 35. | Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26:77-82. |
| 36. | Hägg S, Thorn LM, Putaala J, Liebkind R, Harjutsalo V, Forsblom CM, et al. Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care 2013;36:4140-6. |
| 37. | Lloyd CE, Klein R, Maser RE, Kuller LH, Becker DJ, Orchard TJ. The progression of retinopathy over 2 years: The Pittsburgh epidemiology of diabetes complications (EDC) study. J Diabetes Complications 1995;9:140-8. |
| 38. | Tong PC, Kong AP, So WY, Ng MH, Yang X, Ng MC, et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes. Diabetes Care 2006;29:2439-44. |
| 39. | Tapp R and Shaw J. Epidemiology of diabetic neuropathy. In: Tesdaye S, Boulton A, eds. Oxford, UK: Oxford University Press; 2009. |
| 40. | Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig 2014;5:714-21. |
| 41. | Dutta A, Naorem S, Singh TP, Wangjam K. Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics. Int J Diabetes Dev Ctries 2005;25:30-3. |
| 42. | Miguel GA, Fernández EG, Rodríguez JCR, Pablos DL, Díaz-Guerra GM, Hawkins FG. Association Between Peripheral Neuropathy and Macrovascular Disease in Diabetic Patients. Presented at Endocrine Society's 97th Annual Meeting and Expo, March 5-8; San Diego; 2015. |
| 43. | Chawla R, Rathore P, editor. To Study the Prevalence of Diabetic Peripheral Neuropathy by Biothesiometric Evaluation & It's Co-association with Other Complications 2004(NNDU Proceedings 2004); 2004. |
| 44. | Chawla R, Poddar A, Chawla R. High Prevalence of CAN in New Onset T-2 Diabetes Patients. Presented on American Diabetes Association's 68 th Scientific Session; June 8; San Francisco, CA; 2008. |
| 45. | Chawla R, Gupta S, Punyani H. Correlation Between Autonomic Neuropathy and Distal Peripheral Neuropathy and Its Co-association with Peripheral Vascular Disease in Type-2 Diabetes Mellitus Patients. Presented on American Diabetes Association's 70 th Scientific Session; June 25; Orlando, FL, USA; 2010. |
| 46. | Chawla R, Rathore P. Evaluation of Lower Extremity Arterial Disease (LEAD/PVD) in Type-2 Diabetics and Its Co-association with Other Macro Vascular Complications. Presented on Annual Conference of Diabetic Foot Society of India's Scientific Session; September 4-5; Bhopal, India; 2004. |
| 47. | Chawla A, Bhasin GK, Chawla R. Validation of neuropathy symptoms score (NSS) and neuropathy disability score (NDS) in the clinical diagnosis of peripheral neuropathy in middle aged people with diabetes. Internet J Fam Pract 2013;12:1. |
| 48. | Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 2014;18:1-14. |
| 49. | Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994;14:1521-8. |
| 50. | Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 2006;114:597-605. |
| 51. | Kalousová M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51:597-604. |
| 52. | Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999;22:1543-8. |
| 53. | Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 2004;53:131-42. |
| 54. | Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: Avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 2011;7:313-24. |
| 55. | Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-70. |
| 56. | Xie L, Zhu X, Hu Y, Li T, Gao Y, Shi Y, et al. Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs. Invest Ophthalmol Vis Sci 2008;49:4203-9. |
| 57. | Duncan JG. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 2011;1813:1351-9. |
| 58. | Syed Ikmal SI, Zaman Huri H, Vethakkan SR, Wan Ahmad WA. Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. Int J Endocrinol 2013;2013:698567. |
| 59. | Otsuka A, Azuma K, Iesaki T, Sato F, Hirose T, Shimizu T, et al. Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. Diabetologia 2005;48:2667-74. |
| 60. | Tian J, Hu S, Sun Y, Yu H, Han X, Cheng W, et al. Vasa vasorum and plaque progression, and responses to atorvastatin in a rabbit model of atherosclerosis: Contrast-enhanced ultrasound imaging and intravascular ultrasound study. Heart 2013;99:48-54. |
| 61. | Hayden MR, Tyagi SC. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: A malignant transformation. Cardiovasc Diabetol 2004;3:1. |
| 62. | Patel A. Does the role of angiogenesis play a role in atherosclerosis and plaque instability. Anat Physiol 2014;4:147. |
| 63. | Xu J, Lu X, Shi GP. Vasa vasorum in atherosclerosis and clinical significance. Int J Mol Sci 2015;16:11574-608. |
| 64. | Bonnefond A, Saulnier PJ, Stathopoulou MG, Grarup N, Ndiaye NC, Roussel R, et al. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? PLoS One 2013;8:e55921. |
| 65. | Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 2001;107:1083-92. |
| 66. | Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 2001;489:270-6. |
| 67. | Laakso M. Heart in diabetes: A microvascular disease. Diabetes Care 2011;34 Suppl 2:S145-9. |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
Association Between CDKAL1, HHEX, CDKN2A/2B and IGF2BP2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes in Uttarakhand, India |
|
| Amit K Verma,Yamini Goyal,Deepti Bhatt,Mirza Masroor Ali Beg,Kapil Dev,Mohammed A Alsahli,Arshad Husain Rahmani | | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021; Volume 14: 23 | | [Pubmed] | [DOI] | | | 2 |
Novel susceptibility loci identified in a genome-wide association study of type 2 diabetes complications in population of Latvia |
|
| Monta Ustinova,Raitis Peculis,Raimonds Rescenko,Vita Rovite,Linda Zaharenko,Ilze Elbere,Laila Silamikele,Ilze Konrade,Jelizaveta Sokolovska,Valdis Pirags,Janis Klovins | | BMC Medical Genomics. 2021; 14(1) | | [Pubmed] | [DOI] | | | 3 |
Assessment of treatment satisfaction and adherence amongst diabetic patients in governmental primary care clinic of Ramallah, West-Bank |
|
| Maher Khdour,Heba B. Awadallah,Dua’a H. Al-Hamed | | Hospital Practice. 2020; : 1 | | [Pubmed] | [DOI] | | | 4 |
Effect of Lactobacillus delbrueckii Subsp. lactis PTCC1057 on Serum Glucose, Fetuin-A ,and Sestrin 3 Levels in Streptozotocin-Induced Diabetic Mice |
|
| Jamal Hallajzadeh,Reza Dolatyari Eslami,Asghar Tanomand | | Probiotics and Antimicrobial Proteins. 2020; | | [Pubmed] | [DOI] | | | 5 |
Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus |
|
| Emanuel L. Peter,Andrew G. Mtewa,Prakash B. Nagendrappa,Anita Kaligirwa,Crispin Duncan Sesaazi | | Systematic Reviews. 2020; 9(1) | | [Pubmed] | [DOI] | | | 6 |
Percussion Entropy Analysis of Synchronized ECG and PPG Signals as a Prognostic Indicator for Future Peripheral Neuropathy in Type 2 Diabetic Subjects |
|
| Hai-Cheng Wei,Na Ta,Wen-Rui Hu,Sheng-Ying Wang,Ming-Xia Xiao,Xiao-Jing Tang,Jian-Jung Chen,Hsien-Tsai Wu | | Diagnostics. 2020; 10(1): 32 | | [Pubmed] | [DOI] | | | 7 |
Effects of a high concentration of hydrogen on neurological function after traumatic brain injury in diabetic rats |
|
| Ting-Ting Li,Wan-Chao Yang,Yue-Zhen Wang,Tian Sun,Hong-Ling Cao,Jian-Feng Chen,Wen-Zhi Li | | Brain Research. 2020; : 146651 | | [Pubmed] | [DOI] | | | 8 |
NF-?B gene expression in peripheral blood and urine in early diagnosis of diabetic nephropathy – a liquid biopsy approach |
|
| Glaucia Luciano da Veiga,Matheus Gonçalves Della Nina Raffo,Beatriz da Costa Aguiar Alves,Marcelo Rodrigues Bacci,Fernando Luiz Affonso Fonseca | | URINE. 2020; | | [Pubmed] | [DOI] | | | 9 |
Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus |
|
| Amrita K. K. Cheema,Prabhjit Kaur,Amena Fadel,Noura Younes,Mahmoud Zirie,Nasser M Rizk | | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 2409 | | [Pubmed] | [DOI] | | | 10 |
Acute and chronic diabetes complications associated with self-reported oral health: a retrospective cohort study |
|
| Kamini Kaura Parbhakar,Laura C. Rosella,Sonica Singhal,Carlos R. Quiñonez | | BMC Oral Health. 2020; 20(1) | | [Pubmed] | [DOI] | | | 11 |
The impact of diabetes mellitus on health-related quality of life in Saudi Arabia |
|
| Diena M. Almasri,Ahmad O. Noor,Ragia H. Ghoneim,Alaa A. Bagalagel,Mansour Almetwazi,Nujud A. Baghlaf,Esraa A. Hamdi | | Saudi Pharmaceutical Journal. 2020; | | [Pubmed] | [DOI] | | | 12 |
Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities |
|
| Nidhi Raval,Akshant Kumawat,Dnyaneshwar Kalyane,Kiran Kalia,Rakesh K. Tekade | | Drug Discovery Today. 2020; | | [Pubmed] | [DOI] | | | 13 |
Antidiabetic Potential of Prosopis farcta Roots: In Vitro Pancreatic Beta Cell Protection, Enhancement of Glucose Consumption, and Bioassay-Guided Fractionation |
|
| Behzad Shahbazi,Saba Feyzmand,Fataneh Jafari,Nastaran Ghiasvand,Gholamreza Bahrami,Ali Fattahi,Solomon Habtemariam,Seyed-Mohammad Nabavi,Yalda Shokoohinia | | Evidence-Based Complementary and Alternative Medicine. 2020; 2020: 1 | | [Pubmed] | [DOI] | | | 14 |
Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study |
|
| Roqayeh Aliyari,Ebrahim Hajizadeh,Ashraf Aminorroaya,Farshad Sharifi,Iraj Kazemi,Ahmad-Reza Baghestani | | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 1863 | | [Pubmed] | [DOI] | | | 15 |
Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus |
|
| Nasim Sohrabifar,Sayyed Mohammad Hossein Ghaderian,Saeed Alipour Para,Hamid Ghaedi,Hossein Jafari | | Archives of Physiology and Biochemistry. 2020; : 1 | | [Pubmed] | [DOI] | | | 16 |
The Mechanisms of Type 2 Diabetes-Related White Matter Intensities: A Review |
|
| Jing Sun,Baofeng Xu,Xuejiao Zhang,Zhidong He,Ziwei Liu,Rui Liu,Guangxian Nan | | Frontiers in Public Health. 2020; 8 | | [Pubmed] | [DOI] | | | 17 |
Effects of Rutin on Wound Healing in Hyperglycemic Rats |
|
| Li-You Chen,Chien-Ning Huang,Chih-Kai Liao,Hung-Ming Chang,Yu-Hsiang Kuan,To-Jung Tseng,Kai-Jung Yen,Kai-Lin Yang,Hsing-Chun Lin | | Antioxidants. 2020; 9(11): 1122 | | [Pubmed] | [DOI] | | | 18 |
Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-?B and TGF-ß1/Smad3 Signaling Pathways in Diabetic Nephropathy |
|
| Zhi-chao Zheng,Wei Zhu,Lei Lei,Xue-qi Liu,Yong-gui Wu | | Drug Design, Development and Therapy. 2020; Volume 14: 4135 | | [Pubmed] | [DOI] | | | 19 |
Autoimmune Thyroid Disease is Associated with a Lower Prevalence of Diabetic Retinopathy in Patients with Type 1 Diabetic Mellitus |
|
| Magdalena Maria Stefanowicz-Rutkowska,Wojciech Matuszewski,Elzbieta Maria Bandurska-Stankiewicz | | Medicina. 2020; 56(6): 255 | | [Pubmed] | [DOI] | | | 20 |
Palbinone alleviates diabetic retinopathy in STZ-induced rats by inhibiting NLRP3 inflammatory activity |
|
| Qiang Shi,Jianchao Wang,Yuhong Cheng,Xiaomin Dong,Ming Zhang,Cheng Pei | | Journal of Biochemical and Molecular Toxicology. 2020; : e22489 | | [Pubmed] | [DOI] | | | 21 |
Dynamic Phenotypes and Molecular Mechanisms to Understand the Pathogenesis of Diabetic Nephropathy in Two Widely Used Animal Models of Type 2 Diabetes Mellitus |
|
| Yanfei Liu,Hui Huang,Rui Gao,Yue Liu | | Frontiers in Cell and Developmental Biology. 2020; 8 | | [Pubmed] | [DOI] | | | 22 |
Crassocephalum rubens (Juss. Ex Jacq.) S. Moore improves pancreatic histology, insulin secretion, liver and kidney functions and ameliorates oxidative stress in fructose-streptozotocin induced type 2 diabetic rats |
|
| Olajumoke A. Oyebode,Ochuko L. Erukainure,Olakunle Sanni,Md.Shahidul Islam | | Drug and Chemical Toxicology. 2020; : 1 | | [Pubmed] | [DOI] | | | 23 |
Assessment of Drug Therapy Problems Among Type 2 Diabetes Patients with Hypertension Comorbidity in Indonesia |
|
| Julaeha Julaeha,Ery Fudjiati,Aprilita Rina Yanti Eff | | Borneo Journal of Pharmacy. 2020; 3(3): 190 | | [Pubmed] | [DOI] | | | 24 |
Screening of Antioxidant and a-Glucosidase Inhibitory Activities of Indian Medicinal Plants |
|
| Pavan K. Mujawdiya,Suman Kapur | | Current Enzyme Inhibition. 2020; 16(2): 145 | | [Pubmed] | [DOI] | | | 25 |
Asymptomatic Cardiovascular Changes and Complications in Type 2 Diabetes Mellitus |
|
| Ramakrishna Goratla,Kalyankumar P.V,Sravani K | | Journal of Evidence Based Medicine and Healthcare. 2020; 7(35): 1871 | | [Pubmed] | [DOI] | | | 26 |
The safety and efficacy of Momordica charantia
L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis |
|
| Emanuel L. Peter,Prakash B. Nagendrappa,Anita Kaligirwa,Patrick Engeu Ogwang,Crispin Duncan Sesaazi | | Phytotherapy Research. 2020; | | [Pubmed] | [DOI] | | | 27 |
Improving the endothelial dysfunction in type 2 diabetes with chromium and vitamin D3 byreducing homocysteine and oxidative stress: A randomized placebo-controlled trial |
|
| Fatemeh Imanparast,Farideh Jalali Mashayekhi,Fatemeh Kamankesh,Fatemeh Rafiei,Pegah Mohaghegh,Abbas Alimoradian | | Journal of Trace Elements in Medicine and Biology. 2020; 62: 126639 | | [Pubmed] | [DOI] | | | 28 |
Knowledge, Awareness and Prevalence of Diabetic Retinopathy among Patients of Type 2 Diabetes Mellitus on Their First Visit to Eye Department in a Tertiary Health Care Centre - A Hospital Based Cross Sectional Study |
|
| Jasmita Satapathy,Anita Minj,Keya Chakrabarti,Priya Gupta | | Journal of Evidence Based Medicine and Healthcare. 2020; 7(34): 1770 | | [Pubmed] | [DOI] | | | 29 |
Comparison of Serum Brain-Derived Neurotrophic Factor Levels in Diabetic Patients With and Without Retinopathy |
|
| Romana R Rashid,Ayesha Fazal,Qudsia U Khan,Dr. Misbah-ul-Qamar,Farooq Ahmed,Talha Laique | | Cureus. 2020; | | [Pubmed] | [DOI] | | | 30 |
In Silico Design, Synthesis and Evaluation of Novel Series of Benzothiazole- Based Pyrazolidinediones as Potent Hypoglycemic Agents |
|
| Michelyne Haroun | | Medicinal Chemistry. 2020; 16(6): 812 | | [Pubmed] | [DOI] | | | 31 |
Identification of miR-802-5p and its involvement in type 2 diabetes mellitus |
|
| Kaushik Vishnu Rajkumar,Ganesh Lakshmanan,Durairaj Sekar | | World Journal of Diabetes. 2020; 11(12): 567 | | [Pubmed] | [DOI] | | | 32 |
Molecular complexities underlying the vascular complications of diabetes mellitus – A comprehensive review |
|
| Shalini Paul,Azam Ali,Rajesh Katare | | Journal of Diabetes and its Complications. 2020; : 107613 | | [Pubmed] | [DOI] | | | 33 |
Baicalin attenuates Fibrogenic process in human renal proximal tubular cells (HK-2) exposed to diabetic Milieu |
|
| Jung Eun Nam,So Yeon Jo,Chul Woo Ahn,Yu Sik Kim | | Life Sciences. 2020; : 117742 | | [Pubmed] | [DOI] | | | 34 |
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020 |
|
| Rajeev Chawla,SV Madhu,BM Makkar,Sujoy Ghosh,Banshi Saboo,Sanjay Kalra | | Indian Journal of Endocrinology and Metabolism. 2020; 24(1): 1 | | [Pubmed] | [DOI] | | | 35 |
Reduction of hepatorenal and pancreatic damage by Ferula elaeochytris extract in STZ induced diabetic rats |
|
| Ahmet Uyar,Turan Yaman,Omer Faruk Keles,Elif Ebru Alkan,Abdulbaki Demir,Ismail Celik,Zabit Yener | | Biotechnic & Histochemistry. 2020; : 1 | | [Pubmed] | [DOI] | | | 36 |
Does Periodontal Inflammation Affect Type 1 Diabetes in Childhood and Adolescence? A Meta-Analysis |
|
| Biagio Rapone,Massimo Corsalini,Ilaria Converti,Maria Teresa Loverro,Antonio Gnoni,Paolo Trerotoli,Elisabetta Ferrara | | Frontiers in Endocrinology. 2020; 11 | | [Pubmed] | [DOI] | | | 37 |
Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma |
|
| Margarita Labkovich,Erica B. Jacobs,Siddharth Bhargava,Louis R. Pasquale,Robert Ritch | | Asia-Pacific Journal of Ophthalmology. 2020; 9(3): 215 | | [Pubmed] | [DOI] | | | 38 |
Potential risks of endoplasmic reticulum stress on vasculopathy in diabetes |
|
| Sagir Mustapha,Mustapha Mohammed,Ismaeel Yunusa,Aida Hanum Ghulam Rasool,Siti Safiah Mokhtar | | Obesity Medicine. 2020; 19: 100274 | | [Pubmed] | [DOI] | | | 39 |
Additive Effect of Topical Nepafenac on Mydriasis in Patients With Diabetes Mellitus |
|
| Hasan Kiziltoprak,Mustafa Koc,Esat Yetkin,Kemal Tekin,Merve Inanc,Kemal Ozulken | | Eye & Contact Lens: Science & Clinical Practice. 2020; 46(5): 310 | | [Pubmed] | [DOI] | | | 40 |
Active ingredients and mechanisms of Phellinus linteus (grown on Rosa multiflora) for alleviation of Type 2 diabetes mellitus through network pharmacology |
|
| Ki Kwang Oh,Md Adnan,Dong Ha Cho | | Gene. 2020; : 145320 | | [Pubmed] | [DOI] | | | 41 |
Diabetes induced renal complications by leukocyte activation of nuclear factor ?-B and its regulated genes expression |
|
| Noura M. Darwish,Yousif M. Elnahas,Fatmah S. AlQahtany | | Saudi Journal of Biological Sciences. 2020; | | [Pubmed] | [DOI] | | | 42 |
The Growing Epidemic of Diabetes Mellitus |
|
| Dragan Lovic,Alexia Piperidou,Ioanna Zografou,Haralambos Grassos,Andreas Pittaras,Athanasios Manolis | | Current Vascular Pharmacology. 2020; 18(2): 104 | | [Pubmed] | [DOI] | | | 43 |
Association of glycaemia control, age and duration of morbidity with the quality of life in patients of type 2 diabetes mellitus attending the tertiary care hospital in field practice area of Ottapalam Palakad |
|
| Kumar Arjit,Amit Kumar Singh | | Journal of Public Health and Epidemiology. 2020; 12(2): 136 | | [Pubmed] | [DOI] | | | 44 |
A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode |
|
| Cristina Pires Camargo,Rafael Hori Nagamine Weschenfelder,Guilherme Moreira da Fonseca,Alexandre Agostinho da Cruz Sousa,Rolf Gemperli | | Acta Cirurgica Brasileira. 2020; 35(7) | | [Pubmed] | [DOI] | | | 45 |
Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response |
|
| Monta Ustinova,Laura Ansone,Ivars Silamikelis,Vita Rovite,Ilze Elbere,Laila Silamikele,Ineta Kalnina,Davids Fridmanis,Jelizaveta Sokolovska,Ilze Konrade,Valdis Pirags,Janis Klovins,Tao Huang | | PLOS ONE. 2020; 15(8): e0237400 | | [Pubmed] | [DOI] | | | 46 |
Neuroprotective effects of mango cv. ‘Ataulfo’ peel and pulp against oxidative stress in streptozotocin-induced diabetic rats |
|
| Rosario Cázares-Camacho,J. Abraham Domínguez-Avila,Humberto Astiazarán-García,Marcelino Montiel-Herrera,Gustavo A. González-Aguilar | | Journal of the Science of Food and Agriculture. 2020; | | [Pubmed] | [DOI] | | | 47 |
Multimodal a-Glucosidase and a-Amylase Inhibition and Antioxidant Effect of the Aqueous and Methanol Extracts from the Trunk Bark of Ceiba pentandra |
|
| Telesphore Benoit Nguelefack,Christian Kuete Fofie,Elvine Pami Nguelefack-Mbuyo,Adeline Kaptue Wuyt | | BioMed Research International. 2020; 2020: 1 | | [Pubmed] | [DOI] | | | 48 |
Changes in QTc and PR Intervals among Indian Type 2 Diabetes Patients with Respect to Prevailing Glycated Hemoglobin Level: a Retrospective Analysis |
|
| Sayak Roy,Guruprasad Bhattacharya,Mridul Bera | | SN Comprehensive Clinical Medicine. 2020; | | [Pubmed] | [DOI] | | | 49 |
Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy |
|
| Inês Preguiça,André Alves,Sara Nunes,Pedro Gomes,Rosa Fernandes,Sofia D. Viana,Flávio Reis | | Nutrients. 2020; 12(1): 250 | | [Pubmed] | [DOI] | | | 50 |
Altered touch perception and associated risk factors in individuals with diabetes mellitus |
|
| Juliana Andreia Fernandes Noronha,Cissa Azevedo,Caroline de Castro Moura,Elaine Custódio Rodrigues Gusmão,Ana Carolina Lima Ramos Cardoso,Tânia Couto Machado Chianca | | Revista Brasileira de Enfermagem. 2020; 73(6) | | [Pubmed] | [DOI] | | | 51 |
Diabetic retinopathy its genetics and single nucleotide polymorphism associated with multi-ethnic cohort – A review |
|
| R. Thiruchelvi,Kiruthiga Raghunathan | | Materials Today: Proceedings. 2020; | | [Pubmed] | [DOI] | | | 52 |
Stem Cells: A Review Encompassing the Literature with a Special Focus on the Side-Lined Miraculous Panacea; Pre-Morula Stem Cells |
|
| Aryendu K. Saini,Rakesh Saini,Himanshu Bansode,Anurag Singh,Lalita Singh | | Current Stem Cell Research & Therapy. 2020; 15(4): 379 | | [Pubmed] | [DOI] | | | 53 |
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020 |
|
| Rajeev Chawla,S. V. Madhu,B. M. Makkar,Sujoy Ghosh,Banshi Saboo,Sanjay Kalra | | International Journal of Diabetes in Developing Countries. 2020; 40(S1): 1 | | [Pubmed] | [DOI] | | | 54 |
Serum electrolytes levels in patients with type 2 diabetes mellitus: a cross-sectional study |
|
| Shridhar Reshma,Sushith Sushith,Mangalore Balakrishna Prathima,DæSa Janice,Gopal R Madan,Pragathi Gowda,Kiran PK Kumar,Mohandas Rai,Bhuvanesh Sukhlal Kalal | | Diabetes mellitus. 2020; 23(3): 223 | | [Pubmed] | [DOI] | | | 55 |
The protective effect of green tea on diabetes-induced hepato-renal pathological changes: a histological and biochemical study |
|
| Tarek Atia,Hader I. Sakr,Ahmed A. Damanhory,Karim Moawad,Moustfa Alsawy | | Archives of Physiology and Biochemistry. 2020; : 1 | | [Pubmed] | [DOI] | | | 56 |
Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway |
|
| Ye Chen,Rui Yan,Bo Li,Jun Liu,Xiaoxia Liu,Wenyu Song,Chunling Zhu | | International Urology and Nephrology. 2020; | | [Pubmed] | [DOI] | | | 57 |
Role of Mitochondrial Stress Protein HSP60 in Diabetes-Induced Neuroinflammation |
|
| Donisha Shani Niharika Keembiya Liyanagamage,Ryan D. Martinus | | Mediators of Inflammation. 2020; 2020: 1 | | [Pubmed] | [DOI] | | | 58 |
Modulation of the antioxidant defense system in liver, kidney, and pancreas tissues of alloxan-induced diabetic rats by camphor |
|
| Parivash Drikvandi,Seifollah Bahramikia,Masoud Alirezaei | | Journal of Food Biochemistry. 2020; | | [Pubmed] | [DOI] | | | 59 |
Biofilms in Diabetic Foot Ulcers: Significance and Clinical Relevance |
|
| Cassandra Pouget,Catherine Dunyach-Remy,Alix Pantel,Sophie Schuldiner,Albert Sotto,Jean-Philippe Lavigne | | Microorganisms. 2020; 8(10): 1580 | | [Pubmed] | [DOI] | | | 60 |
Antiglycaemic potentials and molecular docking studies of the extracts of Cassia alata L. |
|
| Babatunde Joseph Oso,Ige Francis Olaoye | | Beni-Suef University Journal of Basic and Applied Sciences. 2020; 9(1) | | [Pubmed] | [DOI] | | | 61 |
Metformin use in elderly population with diabetes reduced the risk of dementia in a dose-dependent manner, based on the Korean NHIS-HEALS cohort |
|
| Yonghwan Kim,Hyeong-Seop Kim,Jae-woo Lee,Ye-Seul Kim,Hyo-Sun You,Yoon-Jong Bae,Hyeong-cheol Lee,Ye-Eun Han,Eun-A Choi,Joungyoun Kim,Hee-Taik Kang | | Diabetes Research and Clinical Practice. 2020; 170: 108496 | | [Pubmed] | [DOI] | | | 62 |
Association of plasminogen activator inhibitor-1 4G5G Polymorphism with risk of diabetic nephropathy and retinopathy: a systematic review and meta-analysis |
|
| Seyed Alireza Dastgheib,Farzaneh Najafi,Ahmad Shajari,Reza Bahrami,Fatemeh Asadian,Jalal Sadeghizadeh-Yazdi,Elahe Akbarian,Seyed Alireza Emarati,Hossein Neamatzadeh | | Journal of Diabetes & Metabolic Disorders. 2020; | | [Pubmed] | [DOI] | | | 63 |
The relative risk of developing type 2 diabetes among individuals with prediabetes compared with individuals with normoglycaemia: Meta-analysis and meta-regression |
|
| Xin Yi Xu,Angela Yee Man Leung,Robert Smith,Janet Yuen Ha Wong,Pui Hing Chau,Daniel Yee Tak Fong | | Journal of Advanced Nursing. 2020; | | [Pubmed] | [DOI] | | | 64 |
Mechanisms of Antidiabetic Activity of Methanolic Extract of Punica granatum Leaves in Nicotinamide/Streptozotocin-Induced Type 2 Diabetes in Rats |
|
| Shinu Pottathil,Parminder Nain,Mohamed A. Morsy,Jaspreet Kaur,Bandar E. Al-Dhubiab,Sandhya Jaiswal,Anroop B. Nair | | Plants. 2020; 9(11): 1609 | | [Pubmed] | [DOI] | | | 65 |
The neuroprotective effect of simvastatin on the cerebellum of experimentally-induced diabetic rats through klotho upregulation: An immunohistochemical study |
|
| Ola Mohammed Youssef,Amira Ibrahim Morsy,Mona A. El-Shahat,Amany M Shams,Samira Lotfy Abd-Elhady | | Journal of Chemical Neuroanatomy. 2020; 108: 101803 | | [Pubmed] | [DOI] | | | 66 |
Type 1 Diabetes in Youth and Technology-Based Advances in Management |
|
| Christopher Ferber,Catherine S. Mao,Jennifer K. Yee | | Advances in Pediatrics. 2020; | | [Pubmed] | [DOI] | | | 67 |
Ethanol extract of Cissampelos sympodialis ameliorates lung tissue damage in streptozotocin-induced diabetic rats |
|
| Tessio David de Medeiros,Annyelly Tavares Pereira,Flavio Santos da Silva,Raul Hernandes Bortolin,Karinna Veríssimo Meira Taveira,Bento João da Graça Azevedo Abreu,Adriana Augusto de Rezende,Naisandra Bezerra da Silva Farias,José Maria Barbosa Filho,Karina Carla de Paula Medeiros | | Brazilian Journal of Pharmaceutical Sciences. 2020; 56 | | [Pubmed] | [DOI] | | | 68 |
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial |
|
| Mala Dharmalingam,S. R. Aravind,Hemant Thacker,S. Paramesh,Brij Mohan,Manoj Chawla,Arthur Asirvatham,Ramesh Goyal,Jayashri Shembalkar,R. Balamurugan,Pradnya Kadam,Hansraj Alva,Rahul Kodgule,Monika Tandon,Sivakumar Vaidyanathan,Amol Pendse,Rajesh Gaikwad,Sagar Katare,Sachin Suryawanshi,Hanmant Barkate | | Drugs. 2020; | | [Pubmed] | [DOI] | | | 69 |
Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment |
|
| Kepeng Ou,David A. Copland,Sofia Theodoropoulou,Sonja Mertsch,Youjian Li,Jian Liu,Stefan Schrader,Lei Liu,Andrew D. Dick | | Journal of Cellular and Molecular Medicine. 2020; | | [Pubmed] | [DOI] | | | 70 |
Biocompatible fungal chitosan encapsulated phytogenic silver nanoparticles enhanced antidiabetic, antioxidant and antibacterial activity |
|
| Anbazhagan Sathiyaseelan,Kandasamy Saravanakumar,Arokia Vijay Anand Mariadoss,Myeong-Hyeon Wang | | International Journal of Biological Macromolecules. 2020; | | [Pubmed] | [DOI] | | | 71 |
Hyperbaric Oxygen Therapy and Vascular Complications in Diabetes Mellitus |
|
| Ivana Resanovic,Božidarka Zaric,Jelena Radovanovic,Emina Sudar-Milovanovic,Zoran Gluvic,Danimir Jevremovic,Esma R. Isenovic | | Angiology. 2020; 71(10): 876 | | [Pubmed] | [DOI] | | | 72 |
Autologous non-cultured keratinocyte cell suspension in non-healing diabetic ulcers: A preliminary study |
|
| Shruti Barnwal,Ravi Kant,Poonam Yadav | | Journal of Family Medicine and Primary Care. 2020; 9(9): 4686 | | [Pubmed] | [DOI] | | | 73 |
Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence |
|
| Rakesh Kumar Sahay,Vinod Mittal,G Raja Gopal,Sunil Kota,Ghanshyam Goyal,Mahesh Abhyankar,Santosh Revenkar | | Cureus. 2020; | | [Pubmed] | [DOI] | | | 74 |
Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-Associated Complications: A Systematic Review of Preclinical Studies |
|
| Phiwayinkosi V. Dludla,Sonia Silvestri,Patrick Orlando,Kwazi B. Gabuza,Sithandiwe E. Mazibuko-Mbeje,Tawanda M. Nyambuya,Vuyolwethu Mxinwa,Kabelo Mokgalaboni,Rabia Johnson,Christo J. F. Muller,Luca Tiano,Johan Louw,Bongani B. Nkambule | | Nutrients. 2020; 12(3): 739 | | [Pubmed] | [DOI] | | | 75 |
Subendothelial matrix as the playground for “diabetic milieu” factors in development of angiopathy |
|
| K. A. Nizheradze,A. I. Khoruzhenko | | Biopolymers and Cell. 2020; 36(4): 245 | | [Pubmed] | [DOI] | | | 76 |
A UHPLC-QTOF-MS screening provides new insights into the phytochemical composition and biological properties of six Consolida species from Turkey |
|
| Gabriele Rocchetti,Gokhan Zengin,Yavuz Selim Cakmak,Mohamad Fawzi Mahomoodally,Muhammed Fettah Kaya,Sarah Mohammed Alsheikh,Jasmina Glamocilja,Marina Sokovic,Devina Lobine,Luigi Lucini | | Industrial Crops and Products. 2020; 158: 112966 | | [Pubmed] | [DOI] | | | 77 |
Living Day to Day |
|
| Gerald Kayingo,Virginia McCoy Hass | | Physician Assistant Clinics. 2020; 5(2): 213 | | [Pubmed] | [DOI] | | | 78 |
Association between C reactive protein and microvascular and macrovascular dysfunction in sub-Saharan Africans with and without diabetes: the RODAM study |
|
| Charles Frederick Hayfron-Benjamin,Anke H Maitland-van der Zee,Bert-Jan van den Born,Albert G B Amoah,Karlijn A C Meeks,Kerstin Klipstein-Grobusch,Matthias B Schulze,Joachim Spranger,Ina Danquah,Liam Smeeth,Erik J A J Beune,Frank Mockenhaupt,Charles O Agyemang | | BMJ Open Diabetes Research & Care. 2020; 8(1): e001235 | | [Pubmed] | [DOI] | | | 79 |
Early Endothelial Dysfunction in Type 1 Diabetes Is Accompanied by an Impairment of Vascular Smooth Muscle Function: A Meta-Analysis |
|
| Elodie Lespagnol,Luc Dauchet,Mehdi Pawlak-Chaouch,Costantino Balestra,Serge Berthoin,Martin Feelisch,Matthieu Roustit,Julien Boissière,Pierre Fontaine,Elsa Heyman | | Frontiers in Endocrinology. 2020; 11 | | [Pubmed] | [DOI] | | | 80 |
Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise |
|
| Linong Ji,Jianhua Ma,Weiping Lu,Jingdong Liu,Jiao’e Zeng,Jialin Yang,Wei Li,Xiuzhen Zhang,Xinhua Xiao,Gen Takayanagi,Yi Wang | | Journal of Diabetes Investigation. 2020; | | [Pubmed] | [DOI] | | | 81 |
Coumarin-chalcone hybrids targeting insulin receptor: Design, synthesis, anti-diabetic activity, and molecular docking |
|
| Sathish Kumar Konidala,Vijay Kotra,Ravi Chandra Sekhara Reddy Danduga,Phani Kumar Kola | | Bioorganic Chemistry. 2020; 104: 104207 | | [Pubmed] | [DOI] | | | 82 |
Probiotics ameliorate pioglitazone-associated bone loss in diabetic rats |
|
| Ahmad Gholami,Mohammad Hossein Dabbaghmanesh,Younes Ghasemi,Pedram Talezadeh,Farhad Koohpeyma,Nima Montazeri-Najafabady | | Diabetology & Metabolic Syndrome. 2020; 12(1) | | [Pubmed] | [DOI] | | | 83 |
Subclinical macro and microvascular disease is differently associated with depressive symptoms in men and women: Findings from the SABRE population-based study |
|
| Jingyi Wang,Therese Tillin,Alun D. Hughes,Marcus Richards,Naveed Sattar,Chloe Park,Nish Chaturvedi | | Atherosclerosis. 2020; 312: 35 | | [Pubmed] | [DOI] | | | 84 |
Management Practice and Contributing Risk Factors for Chronic Complications Among Type 2 Diabetes Mellitus Adult Patients in Follow-Up at a Tertiary Care Teaching Hospital |
|
| Zenebe Negash,Malede Yismaw | | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 3969 | | [Pubmed] | [DOI] | | | 85 |
Hydrogels in Emerging Technologies for Type 1 Diabetes |
|
| Stephanie Fuchs,Alexander U. Ernst,Long-Hai Wang,Kaavian Shariati,Xi Wang,Qingsheng Liu,Minglin Ma | | Chemical Reviews. 2020; | | [Pubmed] | [DOI] | | | 86 |
Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II |
|
| Jocelyn J. Drinkwater,Timothy M. E. Davis,Valentina Hellbusch,Angus W. Turner,David G. Bruce,Wendy A. Davis | | Cardiovascular Diabetology. 2020; 19(1) | | [Pubmed] | [DOI] | | | 87 |
Exposure to Chinese Famine in Fetal Life and the Risk of Dysglycemiain Adulthood |
|
| Yan Zhang,Chao Song,Meng Wang,Weiyan Gong,Yanning Ma,Zheng Chen,Ganyu Feng,Rui Wang,Hongyun Fang,Jing Fan,Ailing Liu | | International Journal of Environmental Research and Public Health. 2020; 17(7): 2210 | | [Pubmed] | [DOI] | | | 88 |
Prognosis of Diabetic Peripheral Neuropathy via Decomposed Digital Volume Pulse from the Fingertip |
|
| Hai-Cheng Wei,Wen-Rui Hu,Na Ta,Ming-Xia Xiao,Xiao-Jing Tang,Hsien-Tsai Wu | | Entropy. 2020; 22(7): 754 | | [Pubmed] | [DOI] | | | 89 |
Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function |
|
| Liliane Silvano Araújo,Marcos Vinícius da Silva,Crislaine Aparecida da Silva,Maria de Fátima Borges,Heloísa Marcelina da Cunha Palhares,Laura Penna Rocha,Rosana Rosa Miranda Corrêa,Virmondes Rodrigues Júnior,Marlene Antônia dos Reis,Juliana Reis Machado,Partha Mukhopadhyay | | PLOS ONE. 2020; 15(3): e0229765 | | [Pubmed] | [DOI] | | | 90 |
Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA) |
|
| Sanjay Kalra,Sarita Bajaj,AG Unnikrishnan,ManashP Baruah,Rakesh Sahay,V Hardik,Amit Kumar | | Indian Journal of Endocrinology and Metabolism. 2019; 23(3): 312 | | [Pubmed] | [DOI] | | | 91 |
Effect of amodiaquine on the pharmacokinetics of gliclazide in diabetic subjects |
|
| Godwin Ishaku Sambo,Taibat Bakare-Odunola Mojirade,Musa Aminu,Adamu Yakasai Ibrahim,Garba Magaji,Adzu Bulus | | African Journal of Pharmacy and Pharmacology. 2019; 13(11): 139 | | [Pubmed] | [DOI] | | | 92 |
Macro- and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh |
|
| Afsana Afroz,Wen Zhang,Andre Jin Wei Loh,Darryl Xing Jie Lee,Baki Billah | | Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; | | [Pubmed] | [DOI] | | | 93 |
Diabetic foot – invalidating complication of diabetes mellitus |
|
| Oana Manuela Spalatelu,Sergiu Chirila,Leonard Gurgas,Vasile Sârbu | | Medic.ro. 2019; 129 (3)(1): 40 | | [Pubmed] | [DOI] | | | 94 |
The Burden of Undiagnosed Diabetes Mellitus in Adult African Population: A Systematic Review and Meta-Analysis |
|
| Daniel Asmelash,Yemane Asmelash | | Journal of Diabetes Research. 2019; 2019: 1 | | [Pubmed] | [DOI] | | | 95 |
A therapeutic approach towards microRNA29 family in vascular diabetic complications: A boon or curse? |
|
| Aishwarya P. Dasare,Piyush Gondaliya,Akshay Srivastava,Kiran Kalia | | Journal of Diabetes & Metabolic Disorders. 2019; | | [Pubmed] | [DOI] | | | 96 |
Diabetic Vascular Damage: Review of Pathogenesis and Possible Evaluation Technologies |
|
| Sergej Sosunkevic,Andrius Rapalis,Mindaugas Marozas,Jonas Ceponis,Arunas Lukosevicius | | IEEE Access. 2019; 7: 148511 | | [Pubmed] | [DOI] | | | 97 |
Purine metabolites can indicate diabetes progression |
|
| Yogaraje Gowda C. Varadaiah,Senthilkumar Sivanesan,Shivananda B. Nayak,Kashinath R. Thirumalarao | | Archives of Physiology and Biochemistry. 2019; : 1 | | [Pubmed] | [DOI] | | | 98 |
Improved quality of diabetes control reduces complication costs in Bulgaria |
|
| Konstantin Tachkov,Konstantin Mitov,Zornitsa Mitkova,Maria Kamusheva,Maria Dimitrova,Valentina Petkova,Alexandra Savova,Miglena Doneva,Dimitar Tcarukciev,Vasil Valov,Galia Angelova,Manoela Manova,Guenka Petrova | | Biotechnology & Biotechnological Equipment. 2019; 33(1): 814 | | [Pubmed] | [DOI] | | | 99 |
Association of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic vascular complications in type 2 diabetes mellitus |
|
| Agnieszka Gala-Bladzinska,Joanna Czech,Marcin Braun,Marzena Skrzypa,Krzysztof Gargasz,Artur Mazur,Izabela Zawlik | | Advances in Medical Sciences. 2019; 64(1): 137 | | [Pubmed] | [DOI] | | | 100 |
Prevalence of Type 1 and Type 2 Diabetes-Related Complications and Their Association With Determinants Identified in Canada’s Survey on Living With Chronic Diseases—Diabetes Component |
|
| Mohsen Yaghoubi,Kerry Mansell,Hassanali Vatanparast,Megan Steeves,Wu Zeng,Marwa Farag | | Canadian Journal of Diabetes. 2019; | | [Pubmed] | [DOI] | | | 101 |
TRACK (by NEHEP) Implementation: A Bangladesh Scenario |
|
| Abdul Kader Mohiuddin | | Pharmacovigilance and Pharmacoepidemiology. 2019; : 28 | | [Pubmed] | [DOI] | | | 102 |
Endoplasmic Reticulum Stress: A Critical Molecular Driver of Endothelial Dysfunction and Cardiovascular Disturbances Associated with Diabetes |
|
| Hatem Maamoun,Shahenda Abdelsalam,Asad Zeidan,Hesham Korashy,Abdelali Agouni | | International Journal of Molecular Sciences. 2019; 20(7): 1658 | | [Pubmed] | [DOI] | | | 103 |
Frequency of Diabetes Foot Ulcer and Related Factors Among Adult Diabetic Patients in the Diabetes Center of Kerman, Iran |
|
| Ali Khalooei,Mansour Mahmoodi Meymand | | Shiraz E-Medical Journal. 2019; In Press(In Press) | | [Pubmed] | [DOI] | | | 104 |
Digital Volume Pulse Measured at the Fingertip as an Indicator of Diabetic Peripheral Neuropathy in the Aged and Diabetic |
|
| Hai-Cheng Wei,Na Ta,Wen-Rui Hu,Ming-Xia Xiao,Xiao-Jing Tang,Bagus Haryadi,Juin J. Liou,Hsien-Tsai Wu | | Entropy. 2019; 21(12): 1229 | | [Pubmed] | [DOI] | | | 105 |
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study |
|
| Michele Colaci,Dilia Giuggioli,Amelia Spinella,Caterina Vacchi,Federica Lumetti,Anna Vittoria Mattioli,Francesca Coppi,Vincenzo Aiello,Maria Perticone,Lorenzo Malatino,Clodoveo Ferri | | Clinical Rheumatology. 2019; | | [Pubmed] | [DOI] | | | 106 |
Economic Impact of Diabetes in Africa |
|
| Clarisse Mapa-Tassou,Jean-Claude Katte,Camille Mba Maadjhou,Jean Claude Mbanya | | Current Diabetes Reports. 2019; 19(2) | | [Pubmed] | [DOI] | | | 107 |
A systematic review on the mechanisms of vitamin K effects on the complications of diabetes and pre-diabetes |
|
| Nahid Karamzad,Vahid Maleki,Kristin Carson-Chahhoud,Samaneh Azizi,Amirhossein Sahebkar,Bahram Pourghassem Gargari | | BioFactors. 2019; | | [Pubmed] | [DOI] | | | 108 |
Is it necessary to screen patient with adhesive capsulitis of shoulder for diabetes mellitus? |
|
| SK Rai,Manoj Kashid,Barun Chakrabarty,Vimal Upreti,Omna Shaki | | Journal of Family Medicine and Primary Care. 2019; 8(9): 2927 | | [Pubmed] | [DOI] | | | 109 |
Effects of Moringa oleifera on oxidative stress, apoptotic and inflammatory biomarkers in streptozotocin-induced diabetic animal model |
|
| O.O. Oguntibeju,G.Y. Aboua,E.I. Omodanisi | | South African Journal of Botany. 2019; | | [Pubmed] | [DOI] | | | 110 |
Effect of Rosmarinic Acid and Sinapic Acid on Oxidative Stress Parameters in the Cardiac Tissue and Serum of Type 2 Diabetic Female Rats |
|
| Maria Zych,Weronika Wojnar,Slawomir Borymski,Katarzyna Szalabska,Piotr Bramora,Ilona Kaczmarczyk-Sedlak | | Antioxidants. 2019; 8(12): 579 | | [Pubmed] | [DOI] | | | 111 |
Effects of Allium tuncelianum on oxidative stress and hyperglycemia in rats with diabetes mellitus induced by streptozotocin |
|
| Gözde Atilla,Ali Bilgili,Hamit Uslu,Dinçer Erdag,Oktay Özkan | | Ankara Üniversitesi Veteriner Fakültesi Dergisi. 2019; | | [Pubmed] | [DOI] | | | 112 |
Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism |
|
| Kamesh Venkatakrishnan,Hui-Fang Chiu,Chin-Kun Wang | | Journal of Functional Foods. 2019; 57: 425 | | [Pubmed] | [DOI] | | | 113 |
Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials |
|
| D. Papamichou,D.B. Panagiotakos,C. Itsiopoulos | | Nutrition, Metabolism and Cardiovascular Diseases. 2019; | | [Pubmed] | [DOI] | | | 114 |
Foot Kinetic and Kinematic Profile in Type 2 Diabetes Mellitus with Peripheral Neuropathy |
|
| Animesh Hazari,Arun G. Maiya,K.N. Shivashankara | | Journal of the American Podiatric Medical Association. 2019; 109(1): 36 | | [Pubmed] | [DOI] | | | 115 |
From Table to Stable: A Comparative Review of Selected Aspects of Human and Equine Metabolic Syndrome |
|
| Valentina M. Ragno,Gordon A. Zello,Colby D. Klein,Julia B. Montgomery | | Journal of Equine Veterinary Science. 2019; 79: 131 | | [Pubmed] | [DOI] | | | 116 |
Molecular Concept of Diabetic Wound Healing: Effective Role of Herbal Remedies |
|
| Amro Mohamed Soliman,Seong Lin Teoh,Norzana Abd Ghafar,Srijit Das | | Mini-Reviews in Medicinal Chemistry. 2019; 19(5): 381 | | [Pubmed] | [DOI] | | | 117 |
Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease |
|
| Jia Guo,Zhangsuo Liu,Rujun Gong | | Clinical Science. 2019; 133(12): 1321 | | [Pubmed] | [DOI] | | | 118 |
Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease |
|
| Rachael Ann O’Neill,Patrick Gallagher,Tricia Douglas,Julie-Anne Little,Alexander Peter Maxwell,Giuliana Silvestri,Gareth McKay | | BMC Nephrology. 2019; 20(1) | | [Pubmed] | [DOI] | | | 119 |
The Impact of a Community-Based Food Education Program on Nutrition-Related Knowledge in Middle-Aged and Older Patients with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial |
|
| Carlos Vasconcelos,António Almeida,Maria Cabral,Elisabete Ramos,Romeu Mendes | | International Journal of Environmental Research and Public Health. 2019; 16(13): 2403 | | [Pubmed] | [DOI] | | | 120 |
The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance |
|
| Amirhossein Abdelsalam,Amirhossein Korashy,Amirhossein Zeidan,Amirhossein Agouni | | Biomolecules. 2019; 9(7): 286 | | [Pubmed] | [DOI] | | | 121 |
Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications |
|
| Eman Mounir Sherif,Abeer Ahmed Abd El Maksood,Omneya Ibrahim Youssef,Nouran Yousef Salah El-Din,Ola Khaled Mohamed Khater | | Journal of Diabetes and its Complications. 2019; | | [Pubmed] | [DOI] | | | 122 |
Automatically Extracting Disease-Disease Association from Literature with a Large Margin Context-Aware Convolutional Neural Network (Preprint) |
|
| Po-Ting Lai,Wei-Liang Lu,Ting-Rung Kuo,Chia-Ru Chung,Jen-Chieh Han,Richard Tzong-Han Tsai,Jorng-Tzong Horng | | JMIR Medical Informatics. 2019; | | [Pubmed] | [DOI] | | | 123 |
Understanding the multifaceted mechanisms of diabetic wound healing and therapeutic application of stem cells conditioned medium in the healing process |
|
| Lai Woon Fui,Michael Phang Weng Lok,Vijayendran Govindasamy,Then Kong Yong,Then Khong Lek,Anjan Kumar Das | | Journal of Tissue Engineering and Regenerative Medicine. 2019; | | [Pubmed] | [DOI] | | | 124 |
Effects of Turmeric (
Curcuma longa)
Extract in streptozocin-induced diabetic model |
|
| Rana Essa,Ahmed M. El Sadek,Marine E. Baset,Mohamed A. Rawash,Diana G. Sami,Marwa T. Badawy,Maha E. Mansour,Hamdino Attia,Mona K. Saadeldin,Ahmed Abdellatif | | Journal of Food Biochemistry. 2019; | | [Pubmed] | [DOI] | | | 125 |
Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients |
|
| Zeynep Mine Coskun,Melike Ersoz,Mine Adas,Veysel Sabri Hancer,Serife Nur Boysan,Mustafa Sait Gonen,Aynur Acar | | Archives of Medical Research. 2019; 50(3): 91 | | [Pubmed] | [DOI] | | | 126 |
Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT) |
|
| Vijay Viswanathan,K.P. Singh | | Diabetes Technology & Therapeutics. 2019; 21(8): 415 | | [Pubmed] | [DOI] | | | 127 |
Higher Levels of ANGPTL5 in the Circulation of Subjects With Obesity and Type 2 Diabetes Are Associated With Insulin Resistance |
|
| Ghazi Alghanim,Mohamed G. Qaddoumi,Nouf Alhasawi,Preethi Cherian,Irina Al-Khairi,Rasheeba Nizam,Fadi Alkayal,Muath Alanbaei,Jaakko Tuomilehto,Jehad Abubaker,Mohamed Abu-Farha,Fahd Al-Mulla | | Frontiers in Endocrinology. 2019; 10 | | [Pubmed] | [DOI] | | | 128 |
Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus |
|
| Weiyue Zhang,Juan Zheng,Xiang Hu,Lulu Chen | | Endocrine. 2019; | | [Pubmed] | [DOI] | | | 129 |
Homocysteine, interleukin-1ß, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness |
|
| Zhenxiang Dai,Yang Jiao,Qingxian Fan,Anning Qi,Liang Xiao,Jingwei Li | | Experimental and Therapeutic Medicine. 2019; | | [Pubmed] | [DOI] | | | 130 |
Estimation of Aldose Reductase Activity and Malondialdehyde Levels in Patients with Type 2 Diabetes Mellitus |
|
| Sandeep Kumar,Ajay Kumar,Mohammad Mustufa Khan | | Biomedical and Pharmacology Journal. 2019; 12(2): 1001 | | [Pubmed] | [DOI] | | | 131 |
Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study |
|
| Richard Ofori-Asenso,Danny Liew,Samanta Lalic,Mohsen Mazidi,Dianna J. Magliano,Zanfina Ademi,J. Simon Bell,Jenni Ilomaki | | Advances in Therapy. 2019; | | [Pubmed] | [DOI] | | | 132 |
DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment |
|
| Momir Mikov,Nebojša Pavlovic,Bojan Stanimirov,Maja Ðanic,Svetlana Golocorbin-Kon,Karmen Stankov,Hani Al-Salami | | European Journal of Drug Metabolism and Pharmacokinetics. 2019; | | [Pubmed] | [DOI] | | | 133 |
Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: An in vitro and in vivo approach |
|
| Shruti Surendran,Rekha Sapkal,David Paul,Satheeshkumar Nanjappan | | Chemico-Biological Interactions. 2019; : 108909 | | [Pubmed] | [DOI] | | | 134 |
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes |
|
| Sharon Mitchell,Belma Malanda,Albertino Damasceno,Robert H. Eckel,Dan Gaita,Kornelia Kotseva,James L. Januzzi,George Mensah,Jorge Plutzky,Maksym Prystupiuk,Lars Ryden,Jorge Thierer,Salim S. Virani,Laurence Sperling | | Global Heart. 2019; 14(3): 215 | | [Pubmed] | [DOI] | | | 135 |
Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels |
|
| Asma AL-Ishaq,Asma Abotaleb,Asma Kubatka,Asma Kajo,Asma Büsselberg | | Biomolecules. 2019; 9(9): 430 | | [Pubmed] | [DOI] | | | 136 |
Acute cardiovascular complications in patients with diabetes and hypertension: management consideration for minor oral surgery |
|
| Ajinath Nanasaheb Jadhav,Pooja Raosaheb Tarte | | Journal of the Korean Association of Oral and Maxillofacial Surgeons. 2019; 45(4): 207 | | [Pubmed] | [DOI] | | | 137 |
Prediction of stump healing in lower limb amputation: a narrative review |
|
| Suhel Ashraff,Muhammad A Siddiqui,Derek Santos,Thomas Carline | | Journal of Wound Care. 2019; 28(Sup12): S18 | | [Pubmed] | [DOI] | | | 138 |
Myricetin ameliorates high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells |
|
| Azadeh Aminzadeh,Hamideh Bashiri | | Cell Biochemistry and Function. 2019; | | [Pubmed] | [DOI] | | | 139 |
VEGF-A and cardiac autonomic function in newly diagnosed type 2 diabetes mellitus: A cross-sectional study at a tertiary care center |
|
| Suresh Ravichandran,Shival Srivastav,PrathameshHaridas Kamble,Shailja Chambial,Ravindra Shukla,Praveen Sharma,RajeshKumar Sharma | | Journal of Family Medicine and Primary Care. 2019; 8(10): 3185 | | [Pubmed] | [DOI] | | | 140 |
The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: An update |
|
| Habib Yaribeygi,Luis E. Simental-Mendía,Maciej Banach,Simona Bo,Amirhossein Sahebkar | | Biomedicine & Pharmacotherapy. 2019; 120: 109526 | | [Pubmed] | [DOI] | | | 141 |
Antioxidant and Anti-Inflammatory Effects of Curcumin Nanoparticles on Drug-Induced Acute Myocardial Infarction in Diabetic Rats |
|
| Asma Boarescu,Asma Boarescu,Asma Boc?an,Asma Gheban,Asma Bulboaca,Asma Nicula,Asma Pop,Asma Râjnoveanu,Asma Bolboaca | | Antioxidants. 2019; 8(10): 504 | | [Pubmed] | [DOI] | | | 142 |
Novel Hybrids of Pyrazolidinedione and Benzothiazole as TZD Analogues. Rationale Design, Synthesis and In Vivo Anti-Diabetic Evaluation |
|
| Michelyne Haroun | | Medicinal Chemistry. 2019; 15(6): 624 | | [Pubmed] | [DOI] | | | 143 |
Dietary antioxidant for disease prevention corroborated by the Nrf2 pathway |
|
| Amany M. Hegazy,Eman M. El-Sayed,Khadiga S. Ibrahim,Amal S. Abdel-Azeem | | Journal of Complementary and Integrative Medicine. 2019; 16(3) | | [Pubmed] | [DOI] | | | 144 |
CASE CONTROL STUDY EVALUATING THE ASSOCIATION OF SERUM MAGNESIUM WITH DIABETES MELLITUS, ITS MICROVASCULAR COMPLICATIONS AND SERUM LIPID PROFILE |
|
| Payal Mukker,Kala Syamala Kumari Narayanan | | Journal of Evidence Based Medicine and Healthcare. 2019; 6(15): 1177 | | [Pubmed] | [DOI] | | | 145 |
Targeted screening for prediabetes and undiagnosed diabetes in a community setting in India |
|
| Thirunavukkarasu Sathish,Jonathan Shaw,Robyn J. Tapp,Rory Wolfe,Kavumpurathu R. Thankappan,Sajitha Balachandran,Brian Oldenburg | | Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; | | [Pubmed] | [DOI] | | | 146 |
Pharmacist-led interventional programs for diabetic patients in Arab countries: A systematic review study |
|
| Ehab Mudher Mikhael,Mohamed Azmi Hassali,Saad Abdulrahman Hussain,Ahmed Ibrahim Nouri,Nizar Shawky | | International Journal of Diabetes in Developing Countries. 2019; | | [Pubmed] | [DOI] | | | 147 |
Mechanisms Involved in Glycemic Control Promoted by Exercise in Diabetics |
|
| Eric Francelino Andrade,Víviam de Oliveira Silva,Débora Ribeiro Orlando,Luciano José Pereira | | Current Diabetes Reviews. 2019; 15(2): 105 | | [Pubmed] | [DOI] | | | 148 |
Aqueous leaf extract of Clinacanthus nutans
improved metabolic indices and sorbitol-related complications in type II diabetic rats (T2D) |
|
| Mustapha Umar Imam,Maznah Ismail,Annie George,Sasikala M. Chinnappan,Ashril Yusof | | Food Science & Nutrition. 2019; | | [Pubmed] | [DOI] | | | 149 |
Randomized Controlled Trial of Physical Exercise in Diabetic Veterans With Length-Dependent Distal Symmetric Polyneuropathy |
|
| Evan B. Stubbs,Morris A. Fisher,Clara M. Miller,Christine Jelinek,Jolene Butler,Conor McBurney,Eileen G. Collins | | Frontiers in Neuroscience. 2019; 13 | | [Pubmed] | [DOI] | | | 150 |
Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis |
|
| Jing Liu,Caiying Li,Wen Chen,Kuanrong He,Huijuan Ma,Boqing Ma,Pei Zhao,Lu Tian | | BioMed Research International. 2019; 2019: 1 | | [Pubmed] | [DOI] | | | 151 |
THE PIVOTAL ROLE OF NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 IN DIABETES-INDUCED ENDOTHELIAL DYSFUNCTION |
|
| Karan Naresh Amin,Elango Bhakkiyalakshmi,Jayasuriya Ravichandran,D.V.L. Sarada,Ramkumar Kunka Mohanram | | Pharmacological Research. 2019; : 104601 | | [Pubmed] | [DOI] | | | 152 |
Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study) |
|
| Amit Gupta | | Current Diabetes Reviews. 2019; 15(6): 510 | | [Pubmed] | [DOI] | | | 153 |
The prevalence of macro and microvascular complications of DM among patients in Ethiopia 1990–2017: Systematic review |
|
| Bayu Begashaw Bekele | | Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; 13(1): 672 | | [Pubmed] | [DOI] | | | 154 |
The association between near-infrared spectroscopy-derived and flow-mediated dilation assessment of vascular responsiveness in the arm |
|
| Rogerio N. Soares,Yasina B. Somani,David N. Proctor,Juan M. Murias | | Microvascular Research. 2019; 122: 41 | | [Pubmed] | [DOI] | | | 155 |
Promising effects of ß-glucans on glyceamic control in diabetes |
|
| Rukiye Bozbulut,Nevin Sanlier | | Trends in Food Science & Technology. 2019; 83: 159 | | [Pubmed] | [DOI] | | | 156 |
Synergistic Anti-diabetic Activity of Gongronema latifolium and Telfairia occidentalis Leaves Extracts on Hepatic Function and Hematological Indices in Wistar Rats |
|
| Paulinus Mfon Udoudoh,Daniel Ejim Uti,Emmanuel E. Edet,Sunday Nkereuwem Etukudoh,Blessing Godwin Ukwak,Uket Nta Obeten,Grace Ufedo Umoru | | Asian Journal of Biological Sciences. 2019; 13(1): 42 | | [Pubmed] | [DOI] | | | 157 |
Dendrimer Based Nanoarchitectures in Diabetes Management: An Overview |
|
| Vijay Mishra,Nishika Yadav,Gaurav K. Saraogi,Murtaza M. Tambuwala,Namita Giri | | Current Pharmaceutical Design. 2019; 25(23): 2569 | | [Pubmed] | [DOI] | | | 158 |
Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events |
|
| Stjepan Šimic,Tomo Svaguša,Ingrid Prkacin,Tomislav Bulum | | Journal of Diabetes & Metabolic Disorders. 2019; | | [Pubmed] | [DOI] | | | 159 |
In-Vitro Antioxidant, Hypoglycemic Activity, and Identification of Bioactive Compounds in Phenol-Rich Extract from the Marine Red Algae Gracilaria edulis (Gmelin) Silva |
|
| Mišo Gunathilaka,Mišo Samarakoon,Mišo Ranasinghe,Mišo Peiris | | Molecules. 2019; 24(20): 3708 | | [Pubmed] | [DOI] | | | 160 |
A systematic review and meta-analysis on the efficacy and safety of traditional Chinese patent medicine Jinqi Jiangtang Tablet in the treatment of type 2 diabetes |
|
| Huijuan Gao,Yingxi Yang,Jianqing Deng,Jiaqi Liang,Weihua Zhang,Xingzhong Feng | | Complementary Therapies in Medicine. 2019; | | [Pubmed] | [DOI] | | | 161 |
Neuroprotective Effect of Hydroxytyrosol in Experimental Diabetic Retinopathy: Relationship with Cardiovascular Biomarkers |
|
| José Antonio González-Correa,María Dolores Rodríguez-Pérez,Lucía Márquez-Estrada,Juan Antonio López-Villodres,José Julio Reyes,Guillermo Rodriguez-Gutierrez,Juan Fernández-Bolaños,José Pedro De La Cruz | | Journal of Agricultural and Food Chemistry. 2018; 66(3): 637 | | [Pubmed] | [DOI] | | | 162 |
Association of carotid intima-media thickness with exercise tolerance test in type 2 diabetic patients |
|
| Ali Momeni,Abdolmajid Taheri,Maryam Mansuri,Ali Bazdar,Morteza Sedehi,Masoud Amiri | | IJC Heart & Vasculature. 2018; 21: 74 | | [Pubmed] | [DOI] | | | 163 |
Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China |
|
| Yizhi Pan,Tianyi Wang,Yanfang Li,Tianwang Guan,Yanxian Lai,Yan Shen,Abudurexiti Zeyaweiding,Tutiguli Maimaiti,Fang Li,Haiyan Zhao,Cheng Liu | | Lipids in Health and Disease. 2018; 17(1) | | [Pubmed] | [DOI] | | | 164 |
Enhanced calcium entry via activation of NOX/PKC underlies increased vasoconstriction induced by methylglyoxal |
|
| Basma G. Eid,Alaa T. Abu-Sharib,Hany M. El-Bassossy,Khadijah Balamash,Sergey V. Smirnov | | Biochemical and Biophysical Research Communications. 2018; | | [Pubmed] | [DOI] | | | 165 |
Increased Prevalence of Type 2 Diabetes–Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait |
|
| Sarah C. Skinner,Mor Diaw,Vincent Pialoux,Maïmouna Ndour Mbaye,Pauline Mury,Philomène Lopez,Delphine Bousquet,Fatou Gueye,Demba Diedhiou,Philippe Joly,Céline Renoux,Djiby Sow,Saliou Diop,Brigitte Ranque,Agnès Vinet,Abdoulaye Samb,Nicolas Guillot,Philippe Connes | | Diabetes Care. 2018; 41(12): 2595 | | [Pubmed] | [DOI] | | | 166 |
Patient reported experience of blood glucose management when undergoing hyperbaric oxygen treatment |
|
| Carol Baines,Geraldine O’Rourke,Charne Miller,Karen Ford,William McGuiness | | Collegian. 2018; | | [Pubmed] | [DOI] | | | 167 |
A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes |
|
| Habib Yaribeygi,Stephen L. Atkin,Matteo Pirro,Amirhossein Sahebkar | | Journal of Cellular Physiology. 2018; | | [Pubmed] | [DOI] | | | 168 |
Diabetic retinopathy awareness and associations with multiple comorbidities: Insights from DIAMOND Study |
|
| Kiran Shah,Alka Gandhi,Sundaram Natarajan | | Indian Journal of Endocrinology and Metabolism. 2018; 22(1): 30 | | [Pubmed] | [DOI] | | | 169 |
Glycaemic indices and haemoglobin A1c as predictors for non-healing ulcers |
|
| Kevin J. Moore,Erin C. Dunn,Erin N. Marcus,Tulay Koru-Sengul | | Journal of Wound Care. 2018; 27(Sup4): S6 | | [Pubmed] | [DOI] | | | 170 |
The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study |
|
| Gyeongsil Lee,Sung Min Kim,Seulggie Choi,Kyuwoong Kim,Su-Min Jeong,Joung Sik Son,Jae-Moon Yun,Sang Min Park | | Cardiovascular Diabetology. 2018; 17(1) | | [Pubmed] | [DOI] | | | 171 |
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes |
|
| María Isabel del Olmo-Garcia,Juan Francisco Merino-Torres | | Journal of Diabetes Research. 2018; 2018: 1 | | [Pubmed] | [DOI] | | | 172 |
Beetle (Ulomoides dermestoides) fat improves diabetes: effect on liver and pancreatic architecture and on PPAR? expression |
|
| E.I. Jasso-Villagomez,M. Garcia-Lorenzana,J.C. Almanza-Perez,M.A. Fortis-Barrera,G. Blancas-Flores,R. Roman-Ramos,L.A. Prado-Barragan,F.J. Alarcon-Aguilar | | Brazilian Journal of Medical and Biological Research. 2018; 51(6) | | [Pubmed] | [DOI] | | | 173 |
Altered expression of WFS1 and NOTCH2 genes associated with diabetic nephropathy in T2DM patients |
|
| Sahar A. Sharaf,Nagwa A. Kantoush,Dina F. Ayoub,Alshaymaa A. Ibrahim,Amaal A. Abdelaal,Rokaya Abdel Aziz,Mahmoud M. ElHefnawi,Amira N. Ahmed | | Diabetes Research and Clinical Practice. 2018; 140: 304 | | [Pubmed] | [DOI] | | | 174 |
Endothelin-1 Regulation Is Entangled in a Complex Web of Epigenetic Mechanisms in Diabetes |
|
| S. BISWAS,B. FENG,A. THOMAS,S. CHEN,E. AREF-ESHGHI,B. SADIKOVIC,S. CHAKRABARTI | | Physiological Research. 2018; : S115 | | [Pubmed] | [DOI] | | | 175 |
Protective Effect of Inulin and the Integrity of the Microvasculature in Diabetes Mellitus |
|
| Wassef Girgiss Nicola,Mina Wassef Girgiss,Aly Mohamed Ezz El-Arab,Dawoud Fakhry Habib,Mohamed qElsayed Elnemr,Nadia Mohamed Ahmed,Eman Refaat Youness | | Biomedical and Pharmacology Journal. 2018; 11(2): 807 | | [Pubmed] | [DOI] | | | 176 |
Effects of High Glucose on the Expression of LAMA1 and Biological Behavior of Choroid Retinal Endothelial Cells |
|
| Guangwei Song,Da Lin,Licheng Bao,Qi Jiang,Yinan Zhang,Haihua Zheng,Qianying Gao | | Journal of Diabetes Research. 2018; 2018: 1 | | [Pubmed] | [DOI] | | | 177 |
ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus |
|
| Cheng Liu,Yanfang Li,Tianwang Guan,Yanxian Lai,Yan Shen,Abudurexiti Zeyaweiding,Haiyan Zhao,Fang Li,Tutiguli Maimaiti | | Cardiovascular Diabetology. 2018; 17(1) | | [Pubmed] | [DOI] | | | 178 |
BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability |
|
| Naoufal Akla,Claire Viallard,Natalija Popovic,Cindy Lora Gil,Przemyslaw Sapieha,Bruno Larrivée | | Arteriosclerosis, Thrombosis, and Vascular Biology. 2018; 38(8): 1821 | | [Pubmed] | [DOI] | | | 179 |
The Big Entity of New RNA World: Long Non-Coding RNAs in Microvascular Complications of Diabetes |
|
| Satish K. Raut,Madhu Khullar | | Frontiers in Endocrinology. 2018; 9 | | [Pubmed] | [DOI] | | | 180 |
Synthesis of newly functionalized 1,4-naphthoquinone derivatives and their effects on wound healing in alloxan-induced diabetic mice |
|
| Silvia Helena Cardoso,Cleidijane Rodrigues de Oliveira,Ari Souza Guimarães,Jadiely Nascimento,Julianderson de Oliveira dos Santos Carmo,Jamylle Nunes de Souza Ferro,Ana Carolina de Carvalho Correia,Emiliano Barreto | | Chemico-Biological Interactions. 2018; 291: 55 | | [Pubmed] | [DOI] | | | 181 |
Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy |
|
| Corey J. Lager,Nazanene H. Esfandiari,Yingying Luo,Angela R. Subauste,Andrew T. Kraftson,Morton B. Brown,Oliver A. Varban,Rasimcan Meral,Ruth B. Cassidy,Catherine K. Nay,Amy L. Lockwood,Darlene Bellers,Colleen M. Buda,Elif A. Oral | | Obesity Surgery. 2018; | | [Pubmed] | [DOI] | | | 182 |
There is a positive association between vitamin B12 deficiency and serum total cholesterol in Iranian type 2 diabetic patients on Metformin |
|
| Mitra Niafar,Golnaz Samadi,Naser Aghamohammadzadeh,Farzad Najafipour,Zeinab Nikniaz | | Nutrition Clinique et Métabolisme. 2018; | | [Pubmed] | [DOI] | | | 183 |
Toll-Like Receptor 4 and Heat-Shock Protein 70: Is it a New Target Pathway for Diabetic Vasculopathies? |
|
| Amanda Almeida de Oliveira,R. Clinton Webb,Kenia Pedrosa Nunes | | Current Drug Targets. 2018; 20(1): 51 | | [Pubmed] | [DOI] | | | 184 |
The impact of diabetes on treatment in general dental practice |
|
| Vinson Yeung,Joht Chandan | | Dental Update. 2018; 45(2): 120 | | [Pubmed] | [DOI] | | | 185 |
Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection—The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress |
|
| Nabeel Quryshi,Laura Norwood Toro,Karima Ait-Aissa,Amanda Kong,Andreas Beyer | | International Journal of Molecular Sciences. 2018; 19(3): 797 | | [Pubmed] | [DOI] | | | 186 |
Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall |
|
| Mojca Lunder,Miodrag Janic,Mišo Šabovic | | Current Vascular Pharmacology. 2018; 17(1): 6 | | [Pubmed] | [DOI] | | | 187 |
Importance and Potential of Dentists in Identifying Patients at High Risk of Diabetes |
|
| Siddardha G. Chandrupatla,Ranadheer Ramachandra,Satyanarayana Dantala,Krishnappa Pushpanjali,Mary Tavares | | Current Diabetes Reviews. 2018; 15(1): 67 | | [Pubmed] | [DOI] | | | 188 |
Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy |
|
| Kuppuswami Jayashree,Md. Yasir,Gandhipuram Periyasamy Senthilkumar,K Ramesh Babu,Vadivelan Mehalingam,Palani Selvam Mohanraj | | Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018; | | [Pubmed] | [DOI] | | | 189 |
A new indanedione derivative alleviates symptoms of diabetes by modulating RAGE-NF-kappaB pathway in db/db mice |
|
| Gulnaz Khan,Meha Fatima Aftab,Bilquees Bano,Khalid Mohammed Khan,Munazza Murtaza,Sonia Siddiqui,M.Hafizur Rehman,Rizwana Sanaullah Waraich | | Biochemical and Biophysical Research Communications. 2018; | | [Pubmed] | [DOI] | | | 190 |
Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension |
|
| Morgan E. Whitaker,Vineet Nair,Shripad Sinari,Parinita Dherange,Balaji Natarajan,Lindsey Trutter,Evan L. Brittain,Anna R. Hemnes,Eric Austin,Kumar Patel,Stephen M. Black,Joe G.N. Garcia,Jason X. Yuan,Rebecca Vanderpool,Franz Rischard,Ayako Makino,Edward J. Bedrick,Ankit A. Desai | | The American Journal of Medicine. 2018; | | [Pubmed] | [DOI] | | | 191 |
Potential of traditionally consumed medicinal herbs, spices, and food plants to inhibit key digestive enzymes geared towards diabetes mellitus management — A systematic review |
|
| A.D. Seetaloo,M.Z. Aumeeruddy,R.R. Rengasamy Kannan,M.F. Mahomoodally | | South African Journal of Botany. 2018; | | [Pubmed] | [DOI] | | | 192 |
Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients |
|
| Sivanandy Palanisamy,Emily Yien,Ling Shi,Low Si,See Qi,Laura Ling,Teng Lun,Yap Chen | | Pharmacy. 2018; 6(3): 57 | | [Pubmed] | [DOI] | | | 193 |
The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters |
|
| Khalid Al-Rubeaan,Khalid Siddiqui,Mohammed A. Al-Ghonaim,Amira M. Youssef,Dhekra AlNaqeeb | | Annals of Saudi Medicine. 2018; 38(1): 46 | | [Pubmed] | [DOI] | | | 194 |
Glycerol dehydration of native and diabetic animal tissues studied by THz-TDS and NMR methods |
|
| O. A. Smolyanskaya,I. J. Schelkanova,M. S. Kulya,E. L. Odlyanitskiy,I. S. Goryachev,A. N. Tcypkin,Ya. V. Grachev,Ya. G. Toropova,V. V. Tuchin | | Biomedical Optics Express. 2018; 9(3): 1198 | | [Pubmed] | [DOI] | | | 195 |
Inhibition of macrophage inflammatory protein-1ß improves endothelial progenitor cell function and ischemia-induced angiogenesis in diabetes |
|
| Ting-Ting Chang,Liang-Yu Lin,Jaw-Wen Chen | | Angiogenesis. 2018; | | [Pubmed] | [DOI] | | | 196 |
Investigation of effects of neurotrophic factors on painful diabetic neuropathy: an experimental study |
|
| Faruk Kilinç,Ramis Çolak,Mete Özcan,Ahmet Ayar | | The European Research Journal. 2018; | | [Pubmed] | [DOI] | | | 197 |
Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling |
|
| Bessi Qorri,Regina-Veronicka Kalaydina,Aleksandra Velickovic,Yekaterina Kaplya,Alexandria Decarlo,Myron Szewczuk | | Cells. 2018; 7(9): 117 | | [Pubmed] | [DOI] | | | 198 |
Topical Application of Adelmidrol + Trans-Traumatic Acid Enhances Skin Wound Healing in a Streptozotocin-Induced Diabetic Mouse Model |
|
| Rosalba Siracusa,Daniela Impellizzeri,Marika Cordaro,Enrico Gugliandolo,Alessio F. Peritore,Rosanna Di Paola,Salvatore Cuzzocrea | | Frontiers in Pharmacology. 2018; 9 | | [Pubmed] | [DOI] | | | 199 |
Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways |
|
| Habib Yaribeygi,Alexandra E. Butler,Stephen L. Atkin,Niki Katsiki,Amirhossein Sahebkar | | Journal of Cellular Physiology. 2018; | | [Pubmed] | [DOI] | | | 200 |
Personal Health Coaching as a Type 2 Diabetes Mellitus Self-Management Strategy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
|
| Meysam Pirbaglou,Joel Katz,Mehras Motamed,Sarah Pludwinski,Krista Walker,Paul Ritvo | | American Journal of Health Promotion. 2018; 32(7): 1613 | | [Pubmed] | [DOI] | | | 201 |
Downregulation of long non-coding RNAs LINC00523 and LINC00994 in type 2 diabetes in an Iranian cohort |
|
| Zahra Mansoori,Hamid Ghaedi,Mirsaber Sadatamini,Rouhollah Vahabpour,Ali Rahimipour,Mehrnoosh Shanaki,Leyla saeidi,Faranak Kazerouni | | Molecular Biology Reports. 2018; | | [Pubmed] | [DOI] | | | 202 |
O-GlcNAc modification of Sp1 mediates hyperglycaemia-induced ICAM-1 up-regulation in endothelial cells |
|
| Yuan Zhang,Yuan Qu,Tian Niu,Haiyan Wang,Kun Liu | | Biochemical and Biophysical Research Communications. 2017; 484(1): 79 | | [Pubmed] | [DOI] | | | 203 |
Dynamics of Diabetes and Obesity: Epidemiological Perspective |
|
| Annette Boles,Ramesh Kandimalla,P. Hemachandra Reddy | | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017; | | [Pubmed] | [DOI] | | | 204 |
Reduced serum milk fat globule-epidermal growth factor 8 (MFG-E8) concentrations are associated with an increased risk of microvascular complications in patients with type 2 diabetes |
|
| Guohua Sun,Juxiang Liu,Guanghao Xia,Lijuan Zhang,Yonghong Li,Zubang Zhou,Yaya LV,Suhong Wei,Jing Liu,Jinxing Quan | | Clinica Chimica Acta. 2017; 466: 201 | | [Pubmed] | [DOI] | | | 205 |
Restoration of Impaired Metabolic Energy Balance (ATP Pool) and Tube Formation Potential of Endothelial Cells under “high glucose”, Diabetic Conditions by the Bioinorganic Polymer Polyphosphate |
|
| Xiaohong Wang,Maximilian Ackermann,Meik Neufurth,Shunfeng Wang,Qiang Li,Qingling Feng,Heinz Schröder,Werner Müller | | Polymers. 2017; 9(11): 575 | | [Pubmed] | [DOI] | | | 206 |
Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications |
|
| Wei Yang,Yun Li,Tian Tian,Li Wang,Pearl Lee,Qi Hua | | BMC Endocrine Disorders. 2017; 17(1) | | [Pubmed] | [DOI] | | | 207 |
Epigenetics in diabetic nephropathy, immunity and metabolism |
|
| Samuel T. Keating,Janna A. van Diepen,Niels P. Riksen,Assam El-Osta | | Diabetologia. 2017; | | [Pubmed] | [DOI] | | | 208 |
Role of protein carbonylation in diabetes |
|
| Markus Hecker,Andreas H. Wagner | | Journal of Inherited Metabolic Disease. 2017; | | [Pubmed] | [DOI] | | | 209 |
Novel insights into DNA methylation and its critical implications in diabetic vascular complications |
|
| Jia Zheng,Jing Cheng,Qian Zhang,Xinhua Xiao | | Bioscience Reports. 2017; 37(2) | | [Pubmed] | [DOI] | | | 210 |
MicroRNA and Diabetic Complications- a clinical perspective |
|
| Baoqi Fan,Andrea On Yan Luk,Juliana C.N. Chan,Ronald Ching Wan Ma | | Antioxidants & Redox Signaling. 2017; | | [Pubmed] | [DOI] | | | 211 |
Prevalence of Osteoporosis in Type 2 Diabetes Mellitus Patients Using Dual Energy X-Ray Absorptiometry (DEXA) Scan |
|
| Shivank Prakash,Ravi. S. Jatti,Shridhar C. Ghagane,S.M. Jali,M.V. Jali | | International Journal of Osteoporosis and Metabolic Disorders. 2017; 10(2): 10 | | [Pubmed] | [DOI] | | | 212 |
Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes |
|
| Cristina Mega,Edite Teixeira-de-Lemos,Rosa Fernandes,Flávio Reis | | Journal of Diabetes Research. 2017; 2017: 1 | | [Pubmed] | [DOI] | | | 213 |
Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation |
|
| Wenpei Chen,Xiaolan Yao,Chenghao Zhou,Ziyang Zhang,Gang Gui,Baoqin Lin | | Mediators of Inflammation. 2017; 2017: 1 | | [Pubmed] | [DOI] | | | 214 |
Mitochondrial miRNAs in diabetes: just the tip of the iceberg |
|
| Rohini Baradan,John M. Hollander,Samarjit Das | | Canadian Journal of Physiology and Pharmacology. 2017; : 1 | | [Pubmed] | [DOI] | | | 215 |
Pancreatic Elastography From Acoustic Radiation Force Impulse Imaging for Evaluation of Diabetic Microangiopathy |
|
| Yu He,Hui Wang,Xiao Ping Li,Juan-Juan Zheng,Chun-Xiang Jin | | American Journal of Roentgenology. 2017; : 1 | | [Pubmed] | [DOI] | | | 216 |
Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction |
|
| Raffaele Altara,Mauro Giordano,Einar S. Nordén,Alessandro Cataliotti,Mazen Kurdi,Saeed N. Bajestani,George W. Booz | | Frontiers in Endocrinology. 2017; 8 | | [Pubmed] | [DOI] | | | 217 |
Expression of JAZF1, ABCC8, KCNJ11and Notch2 genes and vitamin D receptor polymorphisms in type 2 diabetes, and their association with microvascular complications |
|
| Maha A. Rasheed,Nagwa Kantoush,Nagwa Abd El-Ghaffar,Hebatallah Farouk,Solaf Kamel,Alshaymaa Ahmed Ibrahim,Aliaa Shalaby,Eman Mahmoud,Hala M. Raslan,Omneya M. Saleh | | Therapeutic Advances in Endocrinology and Metabolism. 2017; 8(6): 97 | | [Pubmed] | [DOI] | | | 218 |
Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus |
|
| Jian Li,Yanping Gong,Chunlin Li,Yanhui Lu,Yu Liu,Yinghong Shao | | Medicine. 2017; 96(27): e7201 | | [Pubmed] | [DOI] | | | 219 |
Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications |
|
| Saket Gupta,Ashwini Maratha,Jakub Siednienko,Anandan Natarajan,Thusitha Gajanayake,Shu Hoashi,Sinéad Miggin | | Scientific Reports. 2017; 7(1) | | [Pubmed] | [DOI] | | | 220 |
Significance of cardiac and iron profile alteration in diabetic patients |
|
| Nabil A. Hasona | | Comparative Clinical Pathology. 2017; | | [Pubmed] | [DOI] | | | 221 |
Incidence of complications in young-onset diabetes: Comparing type 2 with type 1 (the young diab study) |
|
| Anandakumar Amutha,Ranjit Mohan Anjana,Ulagamathesan Venkatesan,Harish Ranjani,Ranjit Unnikrishnan,K.M. Venkat Narayan,Viswanathan Mohan,Mohammed K. Ali | | Diabetes Research and Clinical Practice. 2017; 123: 1 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
